US6231597B1 - Apparatus and methods for selectively stenting a portion of a vessel wall - Google Patents
Apparatus and methods for selectively stenting a portion of a vessel wall Download PDFInfo
- Publication number
- US6231597B1 US6231597B1 US09/250,710 US25071099A US6231597B1 US 6231597 B1 US6231597 B1 US 6231597B1 US 25071099 A US25071099 A US 25071099A US 6231597 B1 US6231597 B1 US 6231597B1
- Authority
- US
- United States
- Prior art keywords
- catheter
- stent
- vessel
- gear
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 24
- 230000005856 abnormality Effects 0.000 claims abstract description 26
- 229910001092 metal group alloy Inorganic materials 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 10
- 239000000853 adhesive Substances 0.000 claims description 9
- 230000001070 adhesive effect Effects 0.000 claims description 9
- 239000003550 marker Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 238000011282 treatment Methods 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229920000249 biocompatible polymer Polymers 0.000 claims description 2
- 239000004020 conductor Substances 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 210000001367 artery Anatomy 0.000 abstract description 17
- 230000006496 vascular abnormality Effects 0.000 abstract description 6
- 206010002329 Aneurysm Diseases 0.000 description 34
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 12
- 229910001220 stainless steel Inorganic materials 0.000 description 9
- 239000010935 stainless steel Substances 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000003511 endothelial effect Effects 0.000 description 4
- 238000012282 endovascular technique Methods 0.000 description 4
- 239000002905 metal composite material Substances 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- 206010053567 Coagulopathies Diseases 0.000 description 3
- 201000008450 Intracranial aneurysm Diseases 0.000 description 3
- 206010070693 Vascular dissection Diseases 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 210000001627 cerebral artery Anatomy 0.000 description 3
- 230000035602 clotting Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229910001566 austenite Inorganic materials 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 206010060964 Arterial haemorrhage Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 238000012276 Endovascular treatment Methods 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920013641 bioerodible polymer Polymers 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011833 dog model Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229910000734 martensite Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000007658 neurological function Effects 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
- A61B17/12118—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm for positioning in conjunction with a stent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
- A61F2/885—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils comprising a coil including a plurality of spiral or helical sections with alternate directions around a central axis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/92—Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12068—Details concerning the detachment of the occluding device from the introduction device detachable by heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30092—Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/823—Stents, different from stent-grafts, adapted to cover an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0019—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
- A61F2210/0023—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
- A61F2210/0033—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply electrically, e.g. heated by resistor
Definitions
- the present invention relates to apparatus and methods for treating abnormalities or disease states in tortuous vessels.
- this invention relates to stents and delivery systems used to selectively support portions of a vessel wall, such as for treating aneurysms and vascular dissections.
- abnormality refers to any damage or disease state that affects a portion of a vessel wall.
- An aneurysm for example, is an area within an artery where the artery wall integrity has become compromised by age, disease or trauma. As a result, blood pressure within the artery causes a portion of the artery wall to bulge or balloon.
- the portion of the aneurysm attached to the undeformed wall of the parent artery is called the “neck,” and the bulbous pouch of the aneurysm is called the “dome.”
- the dome is considerably thinner and weaker than the undeformed parent artery wall, and therefore is much more prone to rupture.
- a vascular dissection describes vessel damage in which a portion of a vessel wall delaminates, and a flap of vascular tissue may extend into and partially occlude blood flow in the parent artery.
- a portion of a vessel wall is damaged, but the remaining vessel wall is otherwise healthy.
- Vascular abnormalities can rupture and result in debilitating injury or death, depending on the size and location of the rupture and the amount of extra-arterial bleeding.
- an aneurysm located in the brain is called a cerebral aneurysm
- hemorrhagic stroke results when a cerebral aneurysm ruptures.
- large aneurysms located in certain regions of the brain may result in neurologic problems due to so called “mass effect.” This effect is characterized by the enlarged blood filled dome pressing upon important areas of the brain, and may be manifested by symptoms such as seizure, or impaired speech or vision.
- Extravascular methods require delicate brain surgery to place a clip across the neck of the aneurysm to effectively exclude the dome from blood flow through the undeformed parent artery.
- Such surgical treatments can be associated with high trauma, long recovery times, incomplete recovery of all neurologic functions, morbidity and mortality associated with open brain surgery.
- aneurysms located in some extremely sensitive areas, such as those surrounding the brain stem may be inoperable due to the high risk of mortality.
- GDC Guglielmi Detachable Coil
- the exposed portion of the stainless steel coil electrolytically dissolves.
- the remaining portion of the stainless steel coil and push wire then may be withdrawn from the artery, leaving the platinum coil within the dome.
- many such coils typically from 5 to 20 may need to be placed within the dome to prevent blood from entering the aneurysm. Because pressure on the fragile dome is reduced, the risk of rupture is eliminated or greatly reduced.
- Endovascular treatment permits access to vascular lesions through percutaneous introduction of microcatheters through the femoral artery, and therefore involves less patient trauma than an open surgical approach. This often results in a faster recovery and reduced morbidity and mortality.
- Drawbacks of GDC techniques include patient selection issues—the neck of the aneurysm must be of a sufficient size and orientation to allow coil entry, but prevent coil migration after detachment. Because multiple devices often must be placed directly in the fragile dome, each device introduction risks rupturing the dome due to mechanical trauma induced by the device.
- U.S. Pat. No. 5,135,536 to Hillstead describes a stent for treating occlusive vascular disease comprising an expandable wire tube having a reduced diameter for transluminal placement. Once the stent is positioned within a vessel, a balloon catheter is used to expand the stent to support and reinforce the full circumference of the vessel. Such prior art stents typically have high radial strength to resist collapse due to vessel disease.
- U.S. Pat. No. 5,314,444 to Gianturco describes a stent having similar construction and operation.
- vascular abnormalities such as aneurysms
- endovascular stents are designed to provide high radial strength when deployed, and therefore generally are too rigid to negotiate the tortuous anatomy of cerebral vessels.
- a stent once deployed, is often overgrown by thick layer of vessel endothelium, a phenomenon referred to as “neointimal hyperplasia,” there is some reduction of the vessel flow area after placement of the stent. Such reduction in flow area may cause an unacceptable reduction of blood flow in cerebral arteries.
- the struts of the stent covering the neck of the aneurysm may provide a lattice for the growth of new endothelial cells across the neck, permanently excluding it from blood flow through the parent artery.
- Shrinking the aneurysm and resorption of blood within the aneurysm are expected to follow, thus preventing long-term mass effect problems.
- the stent comprises at least one end region that engages a first portion of a circumference of a vessel in a region adjacent to a vessel abnormality to anchor the stent, and a mid-region that extends over a second portion of the circumference of the vessel to span the abnormality, the second portion having a smaller circumferential extent than the first portion.
- the mid-region includes a plurality of members that span the abnormality and form a lattice that occludes the abnormality.
- the lattice also may be covered with a graft material, such as expanded polytetra fluoroethylene (PTFE), or polyester mesh. Because the mid-region extends over the smaller second portion of the circumference, the stent is highly flexible and may result in reduced narrowing of the flow area of the parent artery.
- PTFE expanded polytetra fluoroethylene
- a delivery system comprising a catheter that enables the mid-region of the stent to span the abnormality.
- the catheter comprises a flexible outer catheter on which the stent is releasably mounted, and an inner torsional catheter that selectively engages the outer catheter to rotate the stent to a desired orientation.
- FIG. 1 is a perspective view of an illustrative embodiment of a stent constructed in accordance with the principles of the present invention
- FIG. 2 is an end view of the stent of FIG. 1;
- FIG. 3 is a side view of a member forming the mid-region of the stent of FIG. 1;
- FIG. 4 is a perspective view of an alternative illustrative embodiment of a stent constructed in accordance with the principles of the present invention.
- FIG. 5 is a side view of an illustrative embodiment of a delivery system constructed in accordance with the principles of the present invention.
- FIG. 6 is a sectional view of a distal end of an outer catheter of the delivery system of FIG. 5;
- FIG. 7 is a perspective view, in isolation, of the first torsion gear of FIG. 6;
- FIG. 8 is a sectional view of an inner torsion catheter of the delivery system of FIG. 5;
- FIG. 9 is a perspective view of the second torsion gear of FIG. 8;
- FIG. 10 is a partial cutaway view of the delivery system of FIG. 5;
- FIG. 11A is a partial sectional view of the stent of FIG. 1 and the delivery system of FIG. 5 disposed within a vessel;
- FIG. 11B is a partial sectional view of the stent of FIG. 4 and the delivery system of FIG. 5 disposed within a vessel;
- FIG. 12 is a perspective view of an alternative embodiment of the stent of the present invention.
- FIG. 13 is a perspective view of another alternative embodiment of the stent of the present invention.
- FIG. 14 is a sectional view of an alternative inner torsion catheter of the present invention.
- FIG. 15 is a partial cutaway view of the inner torsion catheter of FIG. 14;
- FIG. 16 is a sectional view of another illustrative inner torsion catheter of the delivery system of FIG. 5;
- FIG. 17 is a perspective view of the second torsion gear of FIG. 16.
- FIG. 18 is a partial cutaway view of the delivery system of FIG. 5 using the inner torsion catheter of FIG. 16 .
- apparatus constructed in accordance with the principles of the present invention includes a stent having at least one end portion that engages a first portion of a circumference of a vessel to anchor the stent, and a mid-region having a plurality of members that extend over a second portion of the circumference of a vessel to span the abnormality, the second portion having a smaller circumferential extent than the first portion.
- a delivery system is provided for orienting the stent within the vessel during deployment.
- Stent 10 shown in FIG. 1 in a deployed state, has a longitudinal axis 12 , mid-region 15 comprising a plurality of elements 14 , and first end 16 and second end 18 .
- Elements 14 of mid-region 15 are formed of a plurality of curved sections 20 joined by a plurality of bends or cusps 22 .
- First and second ends 16 and 18 include curved sections 24 .
- curved sections 24 and 20 When deployed in a vessel, curved sections 24 and 20 preferably have a convex outer surface and engage a first portion and a second portion, respectively, of the circumference of the vessel, the second portion smaller than the first portion. As shown in FIG. 1, curved sections 24 engage a first portion equal to the full circumference of the vessel, whereas curved sections 20 engage a second portion less than the full circumference (e.g., one-quarter, one half or three-quarters, etc.). Curved sections 20 and 24 preferably are oriented generally perpendicularly to longitudinal axis 12 .
- curved sections 24 form a tubular member having central opening 26
- curved sections 20 which have the same deployed diameter as curved sections 24
- curved sections 24 at first and second ends 16 and 18 engage the interior surface of a parent vessel adjacent to the neck of the aneurysm
- curved sections 20 form a plurality of members that span the abnormality to promote clotting and endothelial growth.
- mid-region 15 does not extend over the entire circumference of the vessel when deployed, stent 10 is highly flexible and provides less resistance to blood flow through the parent artery.
- Stent 10 preferably is constructed of a shape-memory material such as nickel-titanium alloy (nitinol) having an austenite phase transition temperature slightly above body temperature.
- the stent may be cooled into the martensite phase and compressed to a reduced delivery diameter, and conditioned to undergo a heat-activated phase transformation to a deployed, expanded state when heated to a temperature slightly above body temperature.
- an electric current may be applied to heat the stent to a temperature at which it transitions to the austenite phase, and assumes an expanded shape.
- the transformation temperature may be set below body temperature, and the stent mechanically constrained.
- Stent 10 may be formed, for example, by wrapping a nitinol wire around a mandrel template, and then conditioning the wire through a series of heat treatments in accordance with methods that are per se known.
- stent 10 may be fabricated from either nitinol or stainless steel tubing or sheets using previously known electron discharge machining (EDM), chemical etching, or laser cutting techniques.
- EDM electron discharge machining
- stent 10 may be formed from a biocompatible or bioerodible polymer.
- FIG. 4 illustrates an alternative embodiment of a stent constructed in accordance with the principles of the present invention.
- Stent 101 is similar to stent 10 , but includes cover 102 that spans elements 14 and is disposed about a portion of the circumference of stent 101 .
- Cover 102 may comprise a typical graft material, such as polyester or expanded PTFE, and may be applied to an exterior or interior surface of elements 14 using a biocompatible adhesive or sutures.
- cover 102 is oriented to span the abnormality to promote clotting and endothelial growth.
- Delivery system 30 for deploying a stent of the present invention is described.
- the delivery system of the present invention advantageously may be used whenever it is desired to align a feature of a device with a region of a vessel.
- Delivery system 30 includes outer catheter 32 having proximal end 34 and distal end 36 , inner torsion catheter 38 having proximal end 40 and distal end 42 , and controller 44 coupled to proximal end of inner torsion catheter 38 by insulated wires 46 .
- outer catheter 32 preferably comprises a highly flexible material, such as polyethylene, silicone, nylon, polyester or polyurethane, having central lumen 52 that accepts guide wire 48 and has first torsion gear 50 mounted on distal end 36 .
- First torsion gear 50 shown in isolation in FIG. 7, preferably comprises a radiopaque and conductive metal, metal composite or metal alloy, and includes cylindrical portion 58 , stepped portion 60 having engagement surface 59 , and lumen 62 extending through portions 58 and 60 .
- Stent 10 is mounted adjacent to distal end 36 of catheter 32 , and/or first torsion gear 50 , for example, by a thermally activated adhesive or polymer, or electrically erodible wire.
- a retractable sheath could retain stent 10 on catheter 32 , allowing stent 10 to expand when the sheath is retracted.
- Distal end 36 of outer catheter 32 also preferably includes radio-opaque marker bands 54 disposed on outer surface 56 , which may be used to identify the longitudinal location of stent 10 relative to the neck of a target aneurysm, and longitudinally-oriented marker band 57 on first torsion gear 50 .
- Marker band 57 enables the physician to determine the circumferential orientation of stent 10 relative to the neck of an abnormality, as described in greater detail below.
- Inner torsion catheter 38 comprises tubular member 64 having second torsion gear 66 coupled to its distal end by clamp ring 68 .
- Insulated wires 46 extend from second torsion gear 66 and through tubular member 64 to controller 44 .
- Tubular member 64 is flexible in the longitudinal direction, but is sufficiently rigid to apply torque to second torsion gear 66 .
- Tubular member 64 preferably comprises a combination of braided metal and metal alloy wires enclosed within a polymer jacket and lubricious coating, or alternatively, a helical coil and metal alloy wires covered with a polymer jacket and lubricious coating.
- Tubular member 64 includes a lumen or bore 70 for accepting a shank portion of second torsion gear 66 .
- second torsion gear 66 shown in isolation, includes cylindrical portion 72 , stepped portion 74 having engagement surface 75 , and shank 76 extending from end face 78 of cylindrical portion 72 .
- Shank 76 fits within bore 70 of tubular member 64 so that when clamp ring 68 is applied, it secures tubular member 64 to shank 76 .
- Second torsion gear 66 preferably comprises an electrically conductive metal, metal composite or metal alloy that is resistively heated when a radio-frequency (“RF”) power is applied from controller 44 through insulated wires 46 .
- RF radio-frequency
- second torsion gear 66 may be selectively resistively heated by controller 44 , so that heat generated in second torsion gear 44 is conducted to and melts the thermally activated adhesive or polymer retaining stent 10 on outer catheter 32 .
- second torsion gear may be configured to electrically couple to first torsion gear 50 , to deliver power to an electrically erodible wire that retains stent 10 on outer catheter 32 .
- engagement surface 75 of second torsion gear 66 is configured to engage engagement surface 59 of first torsion gear 50 , so that rotation of inner torsion catheter 38 causes rotation of distal end 36 of catheter 32 . Accordingly, inner torsion catheter enables mid-region 15 of stent 10 to be oriented so that it spans the neck of an aneurysm.
- outer catheter 32 is percutaneously and transluminally advanced over a guide wire to dispose distal end 36 in a portion of vessel V containing aneurysm A using known radiological techniques.
- stent 10 is disposed across neck N of aneurysm A, for example, by determining the location of marker bands 54 with a fluoroscope, the guide wire is withdrawn.
- Inner torsion catheter 38 is inserted through hemostatic coupling 80 of outer catheter 32 and then advanced and rotated until second torsion gear 66 engages with first torsion gear 50 . Inner torsion catheter 38 is then rotated, for example, as guided by radio-opaque marker band 57 , until the convex portion of mid-region 15 is aligned with and spans neck N of aneurysm A, as depicted in FIG. 11 A. More specifically, rotation of inner torsion catheter 38 and outer catheter 32 may be as a unit. Alternatively, because outer catheter 32 is more flexible than inner torsion catheter 38 , relative movement of inner torsion catheter 38 within outer catheter 32 may simply cause the distal end of the outer catheter to twist while the proximal end of outer catheter 32 remains stationary.
- Controller 44 is then activated to cause an RF current to flow through second torsion gear 66 .
- stent 10 is affixed to distal end 36 of outer catheter 32 by a thermally activated adhesive or polymer, for example, a low temperature biocompatible wax
- the RF power delivered to second torsion gear 66 causes resistive heating of the distal end of the catheter, thereby melting the thermally activated adhesive and permitting the stent to expand to its deployed diameter.
- Delivery system 30 is then withdrawn, leaving stent 10 with mid-region 15 disposed across neck N of aneurysm A.
- Stent 10 serves to alter the hemodynamics within aneurysm A to cause it to clot, and acts as a scaffold for endothelial growth that excludes aneurysm A from vessel V.
- RF power supplied by controller 44 may be delivered to and cause stent 10 to undergo a thermally activated phase change to expand to its deployed state. Applying additional power causes the erosion of the electrically erodible wire.
- FIG. 11B illustrates deployment of stent 101 of FIG. 4 .
- inner torsion catheter 38 is rotated until cover 102 is aligned with and spans neck N of aneurysm A.
- cover 102 acts as a scaffold for endothelial growth that excludes aneurysm A from vessel V.
- insulating wires 46 and controller 44 will be apparent to one of skill in the art of interventional catheter design.
- other release mechanisms may be employed to release stent 10 from distal end 36 of outer catheter 32 , such as the pull-wire arrangement described in U.S. Pat. No. 5,443,500 to Sigwart, which is incorporated herein by reference.
- stent 10 may comprise an elastically expandable, plastically deformable or super-elastic material, rather than thermally-activated material, and may be constructed using other shapes than the arcuate wire portions of the embodiment of FIG. 1 .
- stent 10 may comprise first and second coil-sheet portions 91 and 92 , respectively, such as described in the above-incorporated patent to Sigwart, interconnected by mid-region 93 .
- Coil-sheet portions 91 and 92 and mid-region 93 preferably comprise a mesh having a plurality of openings 94 , so that the lattice formed by openings 94 constitutes a plurality of intersecting members 95 .
- Coiled sheet portions 91 and 92 may be wound to a reduced diameter for transluminal delivery, and then expanded (or permitted to self-expand) once positioned within a vessel so that mid-region 93 spans the abnormality.
- coiled-sheet portions 91 and 92 engage a first portion equal to the full circumference of the vessel, whereas mid-region 93 engages a second portion of the circumference, the second portion less than the first portion.
- stent 10 alternatively may comprise first and second coiled expansile portions 96 and 97 , respectively, interconnected by mid-region 98 .
- Coil-ring portions 96 and 97 and mid-region 98 preferably comprise a mesh having a plurality of openings 99 , so that the lattice formed by openings 99 constitutes a plurality of intersecting members 100 .
- coil-ring portions 96 and 97 engage a first portion less than a full circumference of the vessel, and mid-region 98 engages a second portion of the circumference, the second portion less than the first portion.
- FIGS. 14 and 15 illustrate a distal end of an alternative embodiment of an inner torsion catheter that permits catheter delivery and deployment with a guide wire in the vessel.
- inner torsion catheter 103 comprises tubular member 104 having second torsion gear 105 coupled to its distal end.
- Tubular member 104 includes central lumen 106 , peripheral lumen 107 and bore 108 .
- Peripheral lumen 107 terminates at its distal end with opening 109 in a sidewall of bore 108 .
- Insulated wires 110 (one shown in FIG. 14) extend from second torsion gear 105 and through peripheral lumen 107 to controller 44 .
- Tubular member 104 is flexible in the longitudinal direction, but is sufficiently rigid to apply torque to second torsion gear 105 .
- Tubular member 104 preferably comprises a combination of braided metal and metal alloy wires enclosed within a polymer jacket and lubricious coating, or alternatively, a helical coil and metal alloy wires covered with a polymer jacket and lubricious coating. Bore 108 accepts a shank portion of second torsion gear 105 .
- second torsion gear 105 includes cylindrical portion 111 , stepped portion 112 having engagement surface 113 , shank 114 extending from end face 115 of cylindrical portion 111 and lumen 116 extending through shank 114 , cylindrical portion 111 and stepped portion 112 .
- Shank 114 fits within bore 108 of tubular member 104 and is secured to tubular member 104 with a suitable adhesive, for example epoxy.
- Second torsion gear 105 preferably comprises an electrically conductive metal, metal composite or metal alloy. Insulated wires 110 are electrically bonded to shank 114 , such as by soldering or crimping. Second torsion gear 105 is resistively heated when RF power is applied from controller 44 through insulated wires 110 .
- FIGS. 16-18 illustrate a distal end of a further alternative embodiment of an inner torsion catheter having a guide wire tip.
- second torsion gear 118 includes cylindrical portion 119 , stepped portion 120 having engagement surface 121 and semi-circular bore 122 , and guide wire tip 124 extending from front face 125 of cylindrical portion 119 .
- Guide wire tip 124 includes flexible coiled portion 126 and tapered tip 127 . Proximal end 123 of guide wire tip 124 is engaged in semi-circular bore 122 of stepped portion 120 .
- Coiled portion 126 preferably comprises an electrically insulative, flexible helical coil comprising a plastic or a metal alloy, such as stainless steel, having an electrically insulative cover.
- Tapered tip 127 may comprise a biocompatible material, such as nylon, disposed on the distal end of coiled portion 126 .
- guide wire tip 124 may comprise a short section of a conventional stainless steel guide wire having an electrically insulative cover.
- Second torsion gear 118 preferably comprises an electrically conductive metal, metal composite or metal alloy that is resistively heated when a radio-frequency RF power is applied from controller 44 through insulated wires 46 .
- engagement surface 121 of second torsion gear 118 is configured to engage engagement surface 59 of first torsion gear 50 .
- Guide wire tip 124 extends through lumen 62 in first torsion gear 60 .
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Abstract
Methods and apparatus for treating vascular abnormalities in highly tortuous vessels are provided comprising a stent having at least one end region that engages a first portion of a circumference of a vessel in a region adjacent to an abnormality to anchor the stent, and a mid-region that engages a second portion of the circumference of the vessel wall to span the abnormality, the second portion having a smaller circumferential extent than the first portion. The mid-region includes a plurality of members that span the abnormality and form a lattice that occludes the abnormality. A delivery system also is provided to deliver the stent within a parent artery and orient the mid-region of the stent to span the abnormality.
Description
The present invention relates to apparatus and methods for treating abnormalities or disease states in tortuous vessels. In particular, this invention relates to stents and delivery systems used to selectively support portions of a vessel wall, such as for treating aneurysms and vascular dissections.
Some forms of vascular abnormality or disease states, such as aneurysms and vascular dissections, affect only portions of a vessel. The term “abnormality,” as used herein, refers to any damage or disease state that affects a portion of a vessel wall. An aneurysm, for example, is an area within an artery where the artery wall integrity has become compromised by age, disease or trauma. As a result, blood pressure within the artery causes a portion of the artery wall to bulge or balloon. The portion of the aneurysm attached to the undeformed wall of the parent artery is called the “neck,” and the bulbous pouch of the aneurysm is called the “dome.” The dome is considerably thinner and weaker than the undeformed parent artery wall, and therefore is much more prone to rupture.
A vascular dissection describes vessel damage in which a portion of a vessel wall delaminates, and a flap of vascular tissue may extend into and partially occlude blood flow in the parent artery. In each of these different types of vascular abnormalities, a portion of a vessel wall is damaged, but the remaining vessel wall is otherwise healthy.
Vascular abnormalities can rupture and result in debilitating injury or death, depending on the size and location of the rupture and the amount of extra-arterial bleeding. For example, an aneurysm located in the brain is called a cerebral aneurysm, and hemorrhagic stroke results when a cerebral aneurysm ruptures. In addition to the risk of stroke, large aneurysms located in certain regions of the brain may result in neurologic problems due to so called “mass effect.” This effect is characterized by the enlarged blood filled dome pressing upon important areas of the brain, and may be manifested by symptoms such as seizure, or impaired speech or vision.
Previously known methods for treating cerebral aneurysms include extravascular and endovascular techniques. Extravascular methods require delicate brain surgery to place a clip across the neck of the aneurysm to effectively exclude the dome from blood flow through the undeformed parent artery. Such surgical treatments can be associated with high trauma, long recovery times, incomplete recovery of all neurologic functions, morbidity and mortality associated with open brain surgery. Additionally, aneurysms located in some extremely sensitive areas, such as those surrounding the brain stem, may be inoperable due to the high risk of mortality.
Endovascular techniques, in contrast, treat aneurysms using a microcatheter positioned within the aneurysm or the parent artery. U.S. Pat. No. 5,122,136 to Guglielmi et al. describes one such previously known endovascular technique using a device commonly called a “Guglielmi Detachable Coil” (GDC). A GDC comprises a soft pliable coil made from platinum or platinum alloy that is soldered to a stainless steel coil and push wire. The stainless steel coil and push wire are used to position the platinum coil in the dome of the aneurysm, and position the junction between platinum coil and stainless steel coil near the neck of the aneurysm. A direct current (DC) is applied to the push wire, stainless steel coil and platinum coil to form a thrombogenic mass within the dome and thereby occlude the aneurysm.
By exposing the junction between the platinum coil and its push wire coil to blood and continuing to apply electric current to the push wire, the exposed portion of the stainless steel coil electrolytically dissolves. The remaining portion of the stainless steel coil and push wire then may be withdrawn from the artery, leaving the platinum coil within the dome. Depending on the size of the aneurysm, many such coils (typically from 5 to 20) may need to be placed within the dome to prevent blood from entering the aneurysm. Because pressure on the fragile dome is reduced, the risk of rupture is eliminated or greatly reduced.
Endovascular treatment permits access to vascular lesions through percutaneous introduction of microcatheters through the femoral artery, and therefore involves less patient trauma than an open surgical approach. This often results in a faster recovery and reduced morbidity and mortality. Drawbacks of GDC techniques include patient selection issues—the neck of the aneurysm must be of a sufficient size and orientation to allow coil entry, but prevent coil migration after detachment. Because multiple devices often must be placed directly in the fragile dome, each device introduction risks rupturing the dome due to mechanical trauma induced by the device.
U.S. Pat. No. 5,135,536 to Hillstead describes a stent for treating occlusive vascular disease comprising an expandable wire tube having a reduced diameter for transluminal placement. Once the stent is positioned within a vessel, a balloon catheter is used to expand the stent to support and reinforce the full circumference of the vessel. Such prior art stents typically have high radial strength to resist collapse due to vessel disease. U.S. Pat. No. 5,314,444 to Gianturco describes a stent having similar construction and operation.
Such previously known devices are not suitable for treating vascular abnormalities, such as aneurysms, occurring in highly tortuous vessels. For example, previously known endovascular stents are designed to provide high radial strength when deployed, and therefore generally are too rigid to negotiate the tortuous anatomy of cerebral vessels. In addition, because a stent, once deployed, is often overgrown by thick layer of vessel endothelium, a phenomenon referred to as “neointimal hyperplasia,” there is some reduction of the vessel flow area after placement of the stent. Such reduction in flow area may cause an unacceptable reduction of blood flow in cerebral arteries. Some researchers believe that the higher the percent coverage of an artery by a stent, the more hyperplasia will occur.
As a result of the drawbacks of previously known endovascular techniques, it is desirable to find an alternative solution for treating vessels. In Wakhloo et al., “Self-Expanding and Balloon-Expandable Stents in the Treatment of Carotid Aneurysms: An Experimental Study in a Canine Model,” Am. J. Neuroradiology, 15:493-502 (1994), the authors describe the feasibility of placing a stent across a portion of the neck of an aneurysm to alter the hemodynamics and therefore induce spontaneous clotting of stagnant blood within the dome. Those authors further postulated that the struts of the stent covering the neck of the aneurysm may provide a lattice for the growth of new endothelial cells across the neck, permanently excluding it from blood flow through the parent artery. Shrinking the aneurysm and resorption of blood within the aneurysm are expected to follow, thus preventing long-term mass effect problems.
In view of the foregoing, it would be desirable to provide methods and apparatus to enable a stent to be atraumatically and transluminally inserted into highly tortuous vessels, such as the cerebral arteries.
It further would be desirable to provide methods and apparatus for deploying a stent that spans a portion of a vessel to provide a lattice for the growth of new endothelial cells across the portion.
It also would be desirable to provide methods and apparatus comprising a stent having sufficient radial strength to resist downstream migration within the parent artery, but which is less subject to narrowing of the vessel flow area.
In view of the foregoing, it is an object of this invention to provide methods and apparatus to enable a stent to be atraumatically and transluminally inserted into highly tortuous vessels, such as the cerebral arteries.
It is another object of this invention to provide methods and apparatus for deploying a stent that spans a portion of an vessel to provide a lattice for the growth of new endothelial cells across the portion.
It is a further object of the present invention to provide methods and apparatus comprising a stent having sufficient radial strength to resist downstream migration within the parent artery, but which is less subject to narrowing of the vessel flow area.
These and other objects of the present invention are accomplished by providing a stent and a delivery system for implanting the stent. The stent comprises at least one end region that engages a first portion of a circumference of a vessel in a region adjacent to a vessel abnormality to anchor the stent, and a mid-region that extends over a second portion of the circumference of the vessel to span the abnormality, the second portion having a smaller circumferential extent than the first portion. The mid-region includes a plurality of members that span the abnormality and form a lattice that occludes the abnormality. The lattice also may be covered with a graft material, such as expanded polytetra fluoroethylene (PTFE), or polyester mesh. Because the mid-region extends over the smaller second portion of the circumference, the stent is highly flexible and may result in reduced narrowing of the flow area of the parent artery.
In accordance with the principles of the present invention, a delivery system is provided comprising a catheter that enables the mid-region of the stent to span the abnormality. In a preferred embodiment, the catheter comprises a flexible outer catheter on which the stent is releasably mounted, and an inner torsional catheter that selectively engages the outer catheter to rotate the stent to a desired orientation.
Methods of using the stent and delivery catheter of the present invention are also provided.
Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments, in which:
FIG. 1 is a perspective view of an illustrative embodiment of a stent constructed in accordance with the principles of the present invention;
FIG. 2 is an end view of the stent of FIG. 1;
FIG. 3 is a side view of a member forming the mid-region of the stent of FIG. 1;
FIG. 4 is a perspective view of an alternative illustrative embodiment of a stent constructed in accordance with the principles of the present invention;
FIG. 5 is a side view of an illustrative embodiment of a delivery system constructed in accordance with the principles of the present invention;
FIG. 6 is a sectional view of a distal end of an outer catheter of the delivery system of FIG. 5;
FIG. 7 is a perspective view, in isolation, of the first torsion gear of FIG. 6;
FIG. 8 is a sectional view of an inner torsion catheter of the delivery system of FIG. 5;
FIG. 9 is a perspective view of the second torsion gear of FIG. 8;
FIG. 10 is a partial cutaway view of the delivery system of FIG. 5;
FIG. 11A is a partial sectional view of the stent of FIG. 1 and the delivery system of FIG. 5 disposed within a vessel;
FIG. 11B is a partial sectional view of the stent of FIG. 4 and the delivery system of FIG. 5 disposed within a vessel;
FIG. 12 is a perspective view of an alternative embodiment of the stent of the present invention;
FIG. 13 is a perspective view of another alternative embodiment of the stent of the present invention;
FIG. 14 is a sectional view of an alternative inner torsion catheter of the present invention;
FIG. 15 is a partial cutaway view of the inner torsion catheter of FIG. 14;
FIG. 16 is a sectional view of another illustrative inner torsion catheter of the delivery system of FIG. 5;
FIG. 17 is a perspective view of the second torsion gear of FIG. 16; and
FIG. 18 is a partial cutaway view of the delivery system of FIG. 5 using the inner torsion catheter of FIG. 16.
The present invention provides methods and apparatus for negotiating highly tortuous vessels to treat abnormalities located therein, without suffering from the drawbacks of previously known devices. More particularly, apparatus constructed in accordance with the principles of the present invention includes a stent having at least one end portion that engages a first portion of a circumference of a vessel to anchor the stent, and a mid-region having a plurality of members that extend over a second portion of the circumference of a vessel to span the abnormality, the second portion having a smaller circumferential extent than the first portion. Although the mid-region of the stent is highly flexible, care must be taken to orient the mid-region relative to the abnormality. Accordingly, a delivery system is provided for orienting the stent within the vessel during deployment.
Referring now to FIG. 1, an illustrative stent constructed in accordance with the principles of the present invention is described. Stent 10, shown in FIG. 1 in a deployed state, has a longitudinal axis 12, mid-region 15 comprising a plurality of elements 14, and first end 16 and second end 18. Elements 14 of mid-region 15 are formed of a plurality of curved sections 20 joined by a plurality of bends or cusps 22. First and second ends 16 and 18 include curved sections 24.
When deployed in a vessel, curved sections 24 and 20 preferably have a convex outer surface and engage a first portion and a second portion, respectively, of the circumference of the vessel, the second portion smaller than the first portion. As shown in FIG. 1, curved sections 24 engage a first portion equal to the full circumference of the vessel, whereas curved sections 20 engage a second portion less than the full circumference (e.g., one-quarter, one half or three-quarters, etc.). Curved sections 20 and 24 preferably are oriented generally perpendicularly to longitudinal axis 12.
As illustrated in FIGS. 2 and 3, curved sections 24 form a tubular member having central opening 26, whereas curved sections 20, which have the same deployed diameter as curved sections 24, extend over only a portion of the circumference of the vessel. Accordingly, when stent 10 is deployed in a parent vessel, curved sections 24 at first and second ends 16 and 18 engage the interior surface of a parent vessel adjacent to the neck of the aneurysm, whereas curved sections 20 form a plurality of members that span the abnormality to promote clotting and endothelial growth. Advantageously, because mid-region 15 does not extend over the entire circumference of the vessel when deployed, stent 10 is highly flexible and provides less resistance to blood flow through the parent artery.
FIG. 4 illustrates an alternative embodiment of a stent constructed in accordance with the principles of the present invention. Stent 101 is similar to stent 10, but includes cover 102 that spans elements 14 and is disposed about a portion of the circumference of stent 101. Cover 102 may comprise a typical graft material, such as polyester or expanded PTFE, and may be applied to an exterior or interior surface of elements 14 using a biocompatible adhesive or sutures. When stent 101 is deployed in a parent vessel, cover 102 is oriented to span the abnormality to promote clotting and endothelial growth.
Referring to FIG. 5, delivery system 30 for deploying a stent of the present invention is described. As will be readily apparent, the delivery system of the present invention advantageously may be used whenever it is desired to align a feature of a device with a region of a vessel. Delivery system 30 includes outer catheter 32 having proximal end 34 and distal end 36, inner torsion catheter 38 having proximal end 40 and distal end 42, and controller 44 coupled to proximal end of inner torsion catheter 38 by insulated wires 46.
As illustrated in FIG. 6, outer catheter 32 preferably comprises a highly flexible material, such as polyethylene, silicone, nylon, polyester or polyurethane, having central lumen 52 that accepts guide wire 48 and has first torsion gear 50 mounted on distal end 36. First torsion gear 50, shown in isolation in FIG. 7, preferably comprises a radiopaque and conductive metal, metal composite or metal alloy, and includes cylindrical portion 58, stepped portion 60 having engagement surface 59, and lumen 62 extending through portions 58 and 60. Stent 10 is mounted adjacent to distal end 36 of catheter 32, and/or first torsion gear 50, for example, by a thermally activated adhesive or polymer, or electrically erodible wire. Alternatively, a retractable sheath could retain stent 10 on catheter 32, allowing stent 10 to expand when the sheath is retracted.
Referring to FIG. 8, distal end 42 of inner torsion catheter 38 is described. Inner torsion catheter 38 comprises tubular member 64 having second torsion gear 66 coupled to its distal end by clamp ring 68. Insulated wires 46 extend from second torsion gear 66 and through tubular member 64 to controller 44. Tubular member 64 is flexible in the longitudinal direction, but is sufficiently rigid to apply torque to second torsion gear 66. Tubular member 64 preferably comprises a combination of braided metal and metal alloy wires enclosed within a polymer jacket and lubricious coating, or alternatively, a helical coil and metal alloy wires covered with a polymer jacket and lubricious coating. Tubular member 64 includes a lumen or bore 70 for accepting a shank portion of second torsion gear 66.
With respect to FIG. 9, second torsion gear 66, shown in isolation, includes cylindrical portion 72, stepped portion 74 having engagement surface 75, and shank 76 extending from end face 78 of cylindrical portion 72. Shank 76 fits within bore 70 of tubular member 64 so that when clamp ring 68 is applied, it secures tubular member 64 to shank 76.
As depicted in FIG. 10, engagement surface 75 of second torsion gear 66 is configured to engage engagement surface 59 of first torsion gear 50, so that rotation of inner torsion catheter 38 causes rotation of distal end 36 of catheter 32. Accordingly, inner torsion catheter enables mid-region 15 of stent 10 to be oriented so that it spans the neck of an aneurysm.
Referring now to FIGS. 11A and 11B, illustrative methods of using the delivery system of FIG. 5 to deploy a preferred embodiment of the stent of the present invention are described. First, outer catheter 32 is percutaneously and transluminally advanced over a guide wire to dispose distal end 36 in a portion of vessel V containing aneurysm A using known radiological techniques. Once stent 10 is disposed across neck N of aneurysm A, for example, by determining the location of marker bands 54 with a fluoroscope, the guide wire is withdrawn.
Alternatively, in an embodiment where stent 10 is retained on distal end 36 by an electrically erodible wire coupled to first torsion gear 50, RF power supplied by controller 44 may be delivered to and cause stent 10 to undergo a thermally activated phase change to expand to its deployed state. Applying additional power causes the erosion of the electrically erodible wire.
FIG. 11B illustrates deployment of stent 101 of FIG. 4. As shown in FIG. 11B, during deployment, inner torsion catheter 38 is rotated until cover 102 is aligned with and spans neck N of aneurysm A. Once stent 101 expands to its deployed diameter, cover 102 acts as a scaffold for endothelial growth that excludes aneurysm A from vessel V.
Other arrangements of insulating wires 46 and controller 44 will be apparent to one of skill in the art of interventional catheter design. For example, in other embodiments, other release mechanisms may be employed to release stent 10 from distal end 36 of outer catheter 32, such as the pull-wire arrangement described in U.S. Pat. No. 5,443,500 to Sigwart, which is incorporated herein by reference.
In still other embodiments, stent 10 may comprise an elastically expandable, plastically deformable or super-elastic material, rather than thermally-activated material, and may be constructed using other shapes than the arcuate wire portions of the embodiment of FIG. 1.
For example, as depicted in FIG. 12, stent 10 may comprise first and second coil- sheet portions 91 and 92, respectively, such as described in the above-incorporated patent to Sigwart, interconnected by mid-region 93. Coil- sheet portions 91 and 92 and mid-region 93 preferably comprise a mesh having a plurality of openings 94, so that the lattice formed by openings 94 constitutes a plurality of intersecting members 95. Coiled sheet portions 91 and 92 may be wound to a reduced diameter for transluminal delivery, and then expanded (or permitted to self-expand) once positioned within a vessel so that mid-region 93 spans the abnormality. As shown in FIG. 12, when deployed, coiled- sheet portions 91 and 92 engage a first portion equal to the full circumference of the vessel, whereas mid-region 93 engages a second portion of the circumference, the second portion less than the first portion.
As shown in FIG. 13, stent 10 alternatively may comprise first and second coiled expansile portions 96 and 97, respectively, interconnected by mid-region 98. Coil- ring portions 96 and 97 and mid-region 98 preferably comprise a mesh having a plurality of openings 99, so that the lattice formed by openings 99 constitutes a plurality of intersecting members 100. When deployed, coil- ring portions 96 and 97 engage a first portion less than a full circumference of the vessel, and mid-region 98 engages a second portion of the circumference, the second portion less than the first portion.
For certain applications, it may be desirable to keep a guide wire or a guide wire tip in the vessel during stent placement. In particular, the guide wire or guide wire tip may provide additional stability during torquing of the inner and outer catheters. FIGS. 14 and 15 illustrate a distal end of an alternative embodiment of an inner torsion catheter that permits catheter delivery and deployment with a guide wire in the vessel.
As shown in FIG. 14, inner torsion catheter 103 comprises tubular member 104 having second torsion gear 105 coupled to its distal end. Tubular member 104 includes central lumen 106, peripheral lumen 107 and bore 108. Peripheral lumen 107 terminates at its distal end with opening 109 in a sidewall of bore 108. Insulated wires 110 (one shown in FIG. 14) extend from second torsion gear 105 and through peripheral lumen 107 to controller 44. Tubular member 104 is flexible in the longitudinal direction, but is sufficiently rigid to apply torque to second torsion gear 105. Tubular member 104 preferably comprises a combination of braided metal and metal alloy wires enclosed within a polymer jacket and lubricious coating, or alternatively, a helical coil and metal alloy wires covered with a polymer jacket and lubricious coating. Bore 108 accepts a shank portion of second torsion gear 105.
As shown in FIGS. 14 and 15, second torsion gear 105 includes cylindrical portion 111, stepped portion 112 having engagement surface 113, shank 114 extending from end face 115 of cylindrical portion 111 and lumen 116 extending through shank 114, cylindrical portion 111 and stepped portion 112. Shank 114 fits within bore 108 of tubular member 104 and is secured to tubular member 104 with a suitable adhesive, for example epoxy.
FIGS. 16-18 illustrate a distal end of a further alternative embodiment of an inner torsion catheter having a guide wire tip. As shown in FIGS. 16 and 17, second torsion gear 118 includes cylindrical portion 119, stepped portion 120 having engagement surface 121 and semi-circular bore 122, and guide wire tip 124 extending from front face 125 of cylindrical portion 119. Guide wire tip 124 includes flexible coiled portion 126 and tapered tip 127. Proximal end 123 of guide wire tip 124 is engaged in semi-circular bore 122 of stepped portion 120. Coiled portion 126 preferably comprises an electrically insulative, flexible helical coil comprising a plastic or a metal alloy, such as stainless steel, having an electrically insulative cover. Tapered tip 127 may comprise a biocompatible material, such as nylon, disposed on the distal end of coiled portion 126. Alternatively, guide wire tip 124 may comprise a short section of a conventional stainless steel guide wire having an electrically insulative cover.
Although preferred illustrative embodiments of the present invention are described above, a person of ordinary skill in the art will understand that various changes and modifications may be made without departing from the invention. Applicants intend that the appended claims cover all such changes and modifications that fall within the true spirit and scope of the invention.
Claims (25)
1. Apparatus for treating an abnormality in a vessel, the apparatus comprising:
a tubular member including an end region configured to circumferentially engage a first portion of the vessel adjacent to the abnormality;
a mid-region of the tubular member comprising a plurality of members having a convex outer surface that is configured to engage a second portion of the vessel, the second portion being circumferentially smaller than the first portion and less than a full circumference of the vessel, the plurality of members adapted to span the abnormality; and
a delivery system comprising a first catheter having a distal end adapted to support the tubular member and the mid-region, the first catheter having a lumen and a first gear disposed within the lumen for orienting the mid-region so that it spans the abnormality,
wherein a retractable sheath retains the tubular member on the first catheter.
2. The apparatus of claim 1 wherein the tubular member comprises arcuate portions interconnected by a plurality of bends or cusps.
3. The apparatus of claim 1 wherein the tubular member has a longitudinal axis, the plurality of members oriented generally perpendicular to the longitudinal axis.
4. The apparatus of claim 1 wherein the tubular member comprises a coiled sheet.
5. The apparatus of claim 4 wherein the coiled sheet and mid-region comprises a plurality of openings.
6. The apparatus of claim 1 wherein the first portion is substantially equal to the full circumference of the vessel.
7. The apparatus of claim 1 wherein the first portion is less than the full circumference of the vessel.
8. The apparatus of claim 1 wherein the plurality of members engage one-half of the circumference of the vessel.
9. The apparatus of claim 1 wherein the tubular member further comprises a shape memory metal alloy or biocompatible polymer.
10. The apparatus of claim 1 further comprising a graft material covering the mid-region.
11. The apparatus of claim 1, wherein the first gear comprises a lumen that permits a guide wire to extend beyond the distal end of the first catheter into the vessel.
12. The apparatus of claim 1 further comprising a second catheter configured for insertion into the lumen of the first catheter, the second catheter having a distal end and a second gear disposed on the distal end, the second gear configured to engage the first gear when the second catheter is inserted in the lumen.
13. The apparatus of claim 12, wherein: p1 the second gear comprises a guide wire tip; and
the first gear comprises a lumen that permits the guide wire tip to extend beyond the distal end of the first catheter into the vessel.
14. Apparatus for deploying a prosthesis to treat a region of a vessel, the prosthesis having a feature that is adapted to be aligned with the region, the apparatus comprising:
a flexible catheter having a distal end adapted to support the prosthesis, a lumen and a first gear disposed within the lumen, the first gear rotating the flexible catheter to orient the feature so that it is aligned with the region;
a torsion catheter configured for insertion into the lumen of the flexible catheter, the torsion catheter comprising an electrical conductor, a distal end, and a second gear disposed on the distal end, the second gear configured to engage the first gear when the torsion catheter is inserted in the lumen; and
a controller that supplies radio-frequency power to the second gear via the electrical conductor.
15. The apparatus of claim 14, wherein the first gear comprises a lumen that permits a guide wire to extend beyond the distal end of the flexible catheter into the vessel.
16. The apparatus of claim 14, wherein:
the second gear comprises a guide wire tip; and
the first gear comprises a lumen that permits the guide wire tip to extend beyond the distal end of the flexible catheter into the vessel.
17. The apparatus of claim 14, wherein:
the first gear comprises a cylindrical portion and a stepped portion having an engagement surface; and
the second gear comprises a cylindrical portion and a stepped portion having an engagement surface that mates with the engagement surface of the first gear.
18. The apparatus of claim 14, wherein the first gear further comprises a longitudinally-oriented marker band.
19. The apparatus of claim 14 wherein the prosthesis is mounted on the catheter by a thermally activated adhesive or polymer.
20. The apparatus of claim 14 wherein the prosthesis is mounted on the catheter by an electrically erodible wire.
21. Apparatus for deploying a prosthesis to treat a region of a vessel, the prosthesis having a feature that is adapted to be aligned with the region, the apparatus comprising:
a flexible catheter having a distal end adapted to support the prosthesis, a lumen and a first gear disposed within the lumen, the first gear rotating the flexible catheter to orient the feature so that it is aligned with the region,
wherein a retractable sheath retains the prosthesis on the catheter.
22. A method of treating an abnormality at a treatment site within a vessel, the method comprising:
providing a stent having a tubular end region comprising at least one curved section having a convex outer surface that is configured to engage a first portion of the vessel, and a mid-region comprising a plurality of members having a convex outer surface that is configured to engage a second portion of the vessel, the second portion being circumferentially smaller than the first portion and less than a full circumference of the vessel;
providing a delivery system for deploying the stent, the delivery system comprising a first catheter having a distal end configured to support the stent, a lumen, and a first gear disposed within the lumen, and a second catheter having a proximal end, a distal end, and a second gear disposed on the distal end;
transluminally disposing the stent at the treatment site;
inserting the second catheter into the lumen of the first catheter;
engaging the second gear with the first gear;
aligning the mid-region of the stent so that the plurality of members span the abnormality, by rotating a proximal end of the second catheter using the first gear to rotate the distal end of the first catheter;
providing a controller that outputs a radio-frequency power; and
coupling the controller to the second catheter to release the stent from the distal end of the first catheter.
23. The method of claim 22 wherein a thermally activated adhesive or polymer retains the stent on the first catheter, and coupling the controller to the second catheter to release the stent from the distal end of the first catheter further comprises selectively resistively heating a portion of the first catheter to melt the adhesive or polymer to release the stent from the first catheter.
24. The method of claim 22 wherein an electrically erodible wire retains the stent on the first catheter, and coupling the controller to the second catheter to release the stent from the distal end of the first catheter further comprises delivering electrical power to the electrically erodible wire to release the stent from the first catheter.
25. A method of treating an abnormality at a treatment site within a vessel, the method comprising:
providing a stent having tubular end region comprising at least one curved section having a convex outer surface that is configured to engage a first portion of the vessel, and a mid-region comprising a plurality of members having a convex outer surface that is configured to engage a second portion of the vessel, the second portion being circumferentially smaller than the first portion;
providing a delivery system for deploying the stent, the delivery system comprising a first catheter having a distal end configured to receive the stent, a lumen, and a first gear disposed within the lumen;
transluminally disposing the stent at the treatment site;
aligning the mid-region of the stent so that the plurality of members span the abnormality by operating the first gear to rotate the distal end of the first catheter, and wherein a retractable sheath retains the stent on the first catheter; and
retracting the sheath to release the stent from the first catheter.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/250,710 US6231597B1 (en) | 1999-02-16 | 1999-02-16 | Apparatus and methods for selectively stenting a portion of a vessel wall |
AU29929/00A AU2992900A (en) | 1999-02-16 | 2000-02-11 | Apparatus and methods for selectively stenting a portion of a vessel wall |
PCT/US2000/003662 WO2000048517A1 (en) | 1999-02-16 | 2000-02-11 | Apparatus and methods for selectively stenting a portion of a vessel wall |
US09/816,952 US20010012961A1 (en) | 1999-02-16 | 2001-03-22 | Apparatus and methods for selectively stenting a portion of a vessel wall |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/250,710 US6231597B1 (en) | 1999-02-16 | 1999-02-16 | Apparatus and methods for selectively stenting a portion of a vessel wall |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/816,952 Continuation US20010012961A1 (en) | 1999-02-16 | 2001-03-22 | Apparatus and methods for selectively stenting a portion of a vessel wall |
Publications (1)
Publication Number | Publication Date |
---|---|
US6231597B1 true US6231597B1 (en) | 2001-05-15 |
Family
ID=22948845
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/250,710 Expired - Fee Related US6231597B1 (en) | 1999-02-16 | 1999-02-16 | Apparatus and methods for selectively stenting a portion of a vessel wall |
US09/816,952 Abandoned US20010012961A1 (en) | 1999-02-16 | 2001-03-22 | Apparatus and methods for selectively stenting a portion of a vessel wall |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/816,952 Abandoned US20010012961A1 (en) | 1999-02-16 | 2001-03-22 | Apparatus and methods for selectively stenting a portion of a vessel wall |
Country Status (3)
Country | Link |
---|---|
US (2) | US6231597B1 (en) |
AU (1) | AU2992900A (en) |
WO (1) | WO2000048517A1 (en) |
Cited By (179)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020143284A1 (en) * | 2001-04-03 | 2002-10-03 | Hosheng Tu | Drug-releasing trabecular implant for glaucoma treatment |
US20020169130A1 (en) * | 2001-05-03 | 2002-11-14 | Hosheng Tu | Medical device and methods of use for glaucoma treatment |
US20020188308A1 (en) * | 2001-04-07 | 2002-12-12 | Hosheng Tu | Glaucoma stent and methods thereof for glaucoma treatment |
US20030055372A1 (en) * | 1999-04-26 | 2003-03-20 | Lynch Mary G. | Shunt device and method for treating glaucoma |
US20030088260A1 (en) * | 2001-11-08 | 2003-05-08 | Smedley Gregory T. | Combined treatment for cataract and glaucoma treatment |
US20030097151A1 (en) * | 2001-10-25 | 2003-05-22 | Smedley Gregory T. | Apparatus and mitochondrial treatment for glaucoma |
US20030105483A1 (en) * | 2000-05-09 | 2003-06-05 | Hudson John Overton | Nasal packing device |
US6599315B2 (en) | 1999-12-15 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Stent and stent delivery assembly and method of use |
US6607539B1 (en) * | 2001-05-18 | 2003-08-19 | Endovascular Technologies, Inc. | Electric endovascular implant depolyment system |
US6613074B1 (en) * | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
US20030171801A1 (en) * | 2002-03-06 | 2003-09-11 | Brian Bates | Partially covered intraluminal support device |
US6626858B2 (en) | 1999-04-26 | 2003-09-30 | Gmp Vision Solutions, Inc. | Shunt device and method for treating glaucoma |
US20030187385A1 (en) * | 2000-04-14 | 2003-10-02 | Bergheim Olav B. | Implant with anchor |
US6666841B2 (en) | 2001-05-02 | 2003-12-23 | Glaukos Corporation | Bifurcatable trabecular shunt for glaucoma treatment |
US6685735B1 (en) * | 1998-03-30 | 2004-02-03 | Endovascular Technologies, Inc. | Syent/graft deployment catheter with a stent/graft attachment mechanism |
US20040024345A1 (en) * | 2002-04-19 | 2004-02-05 | Morteza Gharib | Glaucoma implant with valveless flow bias |
US20040034429A1 (en) * | 1999-08-18 | 2004-02-19 | Lambrecht Gregg H, | Anchored anulus method |
US20040050392A1 (en) * | 2001-08-28 | 2004-03-18 | Hosheng Tu | Glaucoma stent for treating glaucoma and methods of use |
US20040073299A1 (en) * | 2000-12-16 | 2004-04-15 | Hudson John Overton | Hemostatic device |
WO2004034984A2 (en) * | 2002-10-16 | 2004-04-29 | The General Hospital Corporation | Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
US20040098091A1 (en) * | 2000-11-17 | 2004-05-20 | Raimund Erbel | Endovascular prosthesis |
US20040102729A1 (en) * | 2002-04-08 | 2004-05-27 | David Haffner | Devices and methods for glaucoma treatment |
US20040111050A1 (en) * | 2000-04-14 | 2004-06-10 | Gregory Smedley | Implantable ocular pump to reduce intraocular pressure |
US20040127843A1 (en) * | 2000-04-14 | 2004-07-01 | Hosheng Tu | Glaucoma implant with therapeutic agents |
US20040147870A1 (en) * | 2002-04-08 | 2004-07-29 | Burns Thomas W. | Glaucoma treatment kit |
US6783734B1 (en) * | 1997-06-27 | 2004-08-31 | The United States Of America As Represented By The Department Of Health And Human Services | Convex geometry adhesive film system for laser capture microdissection |
US20040186562A1 (en) * | 2001-07-20 | 2004-09-23 | Cox Brian J. | Aneurysm treatment device and method of use |
US20040225344A1 (en) * | 2003-04-23 | 2004-11-11 | Hoffa Andrew K. | Devices, kits and methods for placing multiple intraluminal medical devices in a body vessel |
US20040230305A1 (en) * | 2002-09-24 | 2004-11-18 | Bogomir Gorensek | Stabilizing device for intervertebral disc, and methods thereof |
US20040267348A1 (en) * | 2003-04-11 | 2004-12-30 | Gunderson Richard C. | Medical device delivery systems |
US20050033401A1 (en) * | 2003-07-17 | 2005-02-10 | Brendan Cunniffe | Methods and devices for placing a fistula device in fluid communication with a target vessel |
US20050038519A1 (en) * | 1999-08-18 | 2005-02-17 | Lambrecht Gregory H. | Method of reducing spinal implant migration |
US20050049578A1 (en) * | 2000-04-14 | 2005-03-03 | Hosheng Tu | Implantable ocular pump to reduce intraocular pressure |
US20050049666A1 (en) * | 2003-08-26 | 2005-03-03 | Chien Thomas Yung-Hui | Stent delivery system |
US20050096732A1 (en) * | 2000-08-18 | 2005-05-05 | Marotta Thomas R. | Endovascular prosthesis |
US6899729B1 (en) * | 2002-12-18 | 2005-05-31 | Advanced Cardiovascular Systems, Inc. | Stent for treating vulnerable plaque |
US20050119636A1 (en) * | 2001-05-02 | 2005-06-02 | David Haffner | Implant with intraocular pressure sensor for glaucoma treatment |
US20050125051A1 (en) * | 2003-12-05 | 2005-06-09 | Scimed Life Systems, Inc. | Detachable segment stent |
US20050192527A1 (en) * | 2001-05-02 | 2005-09-01 | Morteza Gharib | Glaucoma implant with extending members |
US20050240255A1 (en) * | 2004-04-23 | 2005-10-27 | Schaeffer Darin G | Carrier-Based Delivery System for Intraluminal Medical Devices |
US20050250788A1 (en) * | 2004-01-30 | 2005-11-10 | Hosheng Tu | Aqueous outflow enhancement with vasodilated aqueous cavity |
US20050266047A1 (en) * | 2002-04-08 | 2005-12-01 | Hosheng Tu | Injectable glaucoma implants with multiple openings |
US20050271704A1 (en) * | 2002-04-08 | 2005-12-08 | Hosheng Tu | Injectable glaucoma implants with multiple openings |
US20050277864A1 (en) * | 2000-04-14 | 2005-12-15 | David Haffner | Injectable gel implant for glaucoma treatment |
US20060047297A1 (en) * | 2004-08-27 | 2006-03-02 | Case Brian C | Placement of multiple intraluminal medical devices within a body vessel |
US7186232B1 (en) | 2002-03-07 | 2007-03-06 | Glaukoa Corporation | Fluid infusion methods for glaucoma treatment |
US20070118147A1 (en) * | 2002-03-15 | 2007-05-24 | Smedley Gregory T | Combined treatment for cataract and glaucoma treatment |
US7258697B1 (en) | 2003-12-22 | 2007-08-21 | Advanced Cardiovascular Systems, Inc. | Stent with anchors to prevent vulnerable plaque rupture during deployment |
US20070293807A1 (en) * | 2006-05-01 | 2007-12-20 | Lynch Mary G | Dual drainage pathway shunt device and method for treating glaucoma |
US20080071353A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Scimed, Inc. | Endoprosthesis containing magnetic induction particles |
US20080071348A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Scimed, Inc. | Medical Devices |
US20080119943A1 (en) * | 2006-11-16 | 2008-05-22 | Armstrong Joseph R | Stent having flexibly connected adjacent stent elements |
US20080172204A1 (en) * | 2007-01-15 | 2008-07-17 | Fujitsu Limited | Step counter and method of counting steps |
WO2008148014A2 (en) * | 2007-05-23 | 2008-12-04 | C.R. Bard, Inc. | Polymer coated stent |
US7488303B1 (en) | 2002-09-21 | 2009-02-10 | Glaukos Corporation | Ocular implant with anchor and multiple openings |
US7500978B2 (en) | 2003-06-20 | 2009-03-10 | Intrinsic Therapeutics, Inc. | Method for delivering and positioning implants in the intervertebral disc environment |
US20090069880A1 (en) * | 2006-02-03 | 2009-03-12 | Design & Performance - Cyprus Limited | Implantable graft assembly and aneurysm treatment |
US7507243B2 (en) | 1999-08-18 | 2009-03-24 | Gregory Lambrecht | Devices and method for augmenting a vertebral disc |
US20090123914A1 (en) * | 2004-09-24 | 2009-05-14 | Ingeneus Inc. | Genomic Assay |
US7553329B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
US20090182413A1 (en) * | 2008-01-11 | 2009-07-16 | Burkart Dustin C | Stent having adjacent elements connected by flexible webs |
US20090270877A1 (en) * | 2005-12-13 | 2009-10-29 | Johnson Kirk L | Detachment Actuator for Use With Medical Device Deployment Systems |
US20090292352A1 (en) * | 2002-06-27 | 2009-11-26 | Boston Scientific Scimed, Inc. | Methods of making medical devices |
US20090306765A1 (en) * | 2008-06-10 | 2009-12-10 | Boston Scientific Scimed, Inc. | Bioerodible Endoprosthesis |
US20100063531A1 (en) * | 2005-11-09 | 2010-03-11 | Merlin Md Pte Ltd. | Medical Device with Non-Circumferential Surface Portion |
US20100106240A1 (en) * | 2008-10-20 | 2010-04-29 | IMDS, Inc. | Systems and Methods for Aneurysm Treatment and Vessel Occlusion |
US7717961B2 (en) | 1999-08-18 | 2010-05-18 | Intrinsic Therapeutics, Inc. | Apparatus delivery in an intervertebral disc |
US7727241B2 (en) | 2003-06-20 | 2010-06-01 | Intrinsic Therapeutics, Inc. | Device for delivering an implant through an annular defect in an intervertebral disc |
US7799048B2 (en) | 2000-05-09 | 2010-09-21 | Arthrocare Corporation | Nasal packing device |
US20100262216A1 (en) * | 2009-04-09 | 2010-10-14 | Medtronic Vascular, Inc. | Stent having a C-shaped body section for use in a bifurcation |
WO2010123911A2 (en) * | 2009-04-22 | 2010-10-28 | Lake Region Medical, Inc. | Aneurysm treatment system, device and method |
US20100280588A1 (en) * | 2009-05-01 | 2010-11-04 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US20110118826A1 (en) * | 2008-07-30 | 2011-05-19 | Boston Scientific Scimed. Inc. | Bioerodible Endoprosthesis |
US7959679B2 (en) | 1999-08-18 | 2011-06-14 | Intrinsic Therapeutics, Inc. | Intervertebral anulus and nucleus augmentation |
US20110160839A1 (en) * | 2009-12-29 | 2011-06-30 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US7972337B2 (en) | 2005-12-28 | 2011-07-05 | Intrinsic Therapeutics, Inc. | Devices and methods for bone anchoring |
US8016869B2 (en) | 2003-03-26 | 2011-09-13 | Biosensors International Group, Ltd. | Guidewire-less stent delivery methods |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8187315B1 (en) | 2006-12-08 | 2012-05-29 | Cardica, Inc. | Partial stent for treatment of a vascular aneurysm |
US8231678B2 (en) | 1999-08-18 | 2012-07-31 | Intrinsic Therapeutics, Inc. | Method of treating a herniated disc |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8323341B2 (en) | 2007-09-07 | 2012-12-04 | Intrinsic Therapeutics, Inc. | Impaction grafting for vertebral fusion |
US8328860B2 (en) | 2007-03-13 | 2012-12-11 | Covidien Lp | Implant including a coil and a stretch-resistant member |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8454612B2 (en) | 2007-09-07 | 2013-06-04 | Intrinsic Therapeutics, Inc. | Method for vertebral endplate reconstruction |
US8506515B2 (en) | 2006-11-10 | 2013-08-13 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US20140025154A1 (en) * | 2012-07-18 | 2014-01-23 | Tyco Healthcare Group Lp | Methods and apparatus for luminal stenting |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8777978B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8801747B2 (en) | 2007-03-13 | 2014-08-12 | Covidien Lp | Implant, a mandrel, and a method of forming an implant |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8858613B2 (en) | 2010-09-20 | 2014-10-14 | Altura Medical, Inc. | Stent graft delivery systems and associated methods |
US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
US9050095B2 (en) | 2004-09-22 | 2015-06-09 | Covidien Lp | Medical implant |
US9095343B2 (en) | 2005-05-25 | 2015-08-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9173775B2 (en) | 2012-03-26 | 2015-11-03 | Glaukos Corporation | System for delivering multiple ocular implants |
US9179962B2 (en) | 2012-10-29 | 2015-11-10 | Ablative Solutions, Inc. | Transvascular methods of treating extravascular tissue |
US9198665B2 (en) | 2004-09-22 | 2015-12-01 | Covidien Lp | Micro-spiral implantation device |
US9204983B2 (en) | 2005-05-25 | 2015-12-08 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9237925B2 (en) | 2011-04-22 | 2016-01-19 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US9278196B2 (en) | 2011-08-24 | 2016-03-08 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US20160113665A1 (en) * | 2013-03-14 | 2016-04-28 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US20160243341A1 (en) * | 2015-02-25 | 2016-08-25 | Terumo Kabushiki Kaisha | Medical device, medical device assembly, balloon device, and treatment method for treating urethral stricture |
US9526827B2 (en) | 2012-10-29 | 2016-12-27 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US9572652B2 (en) | 2009-12-01 | 2017-02-21 | Altura Medical, Inc. | Modular endograft devices and associated systems and methods |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
US9737426B2 (en) | 2013-03-15 | 2017-08-22 | Altura Medical, Inc. | Endograft device delivery systems and associated methods |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US9931046B2 (en) | 2013-10-25 | 2018-04-03 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
US9949652B2 (en) | 2013-10-25 | 2018-04-24 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10058330B2 (en) | 2011-05-11 | 2018-08-28 | Microvention, Inc. | Device for occluding a lumen |
US10118004B2 (en) | 2011-08-24 | 2018-11-06 | Ablative Solutions, Inc. | Expandable catheter system for fluid injection into and deep to the wall of a blood vessel |
US10226278B2 (en) | 2012-10-29 | 2019-03-12 | Ablative Solutions, Inc. | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
US10285833B2 (en) | 2012-08-10 | 2019-05-14 | Lombard Medical Limited | Stent delivery systems and associated methods |
US10299948B2 (en) | 2014-11-26 | 2019-05-28 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US10485951B2 (en) | 2011-08-24 | 2019-11-26 | Ablative Solutions, Inc. | Catheter systems and packaged kits for dual layer guide tubes |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US10517666B2 (en) | 2013-10-25 | 2019-12-31 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US10568752B2 (en) | 2016-05-25 | 2020-02-25 | W. L. Gore & Associates, Inc. | Controlled endoprosthesis balloon expansion |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10736656B2 (en) | 2012-10-29 | 2020-08-11 | Ablative Solutions | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US10842498B2 (en) | 2018-09-13 | 2020-11-24 | Neuravi Limited | Systems and methods of restoring perfusion to a vessel |
US10849685B2 (en) | 2018-07-18 | 2020-12-01 | Ablative Solutions, Inc. | Peri-vascular tissue access catheter with locking handle |
US10881458B2 (en) | 2012-10-29 | 2021-01-05 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US10881541B1 (en) | 2020-05-01 | 2021-01-05 | Krishna Rocha-Singh | Systems and methods for treating venous compression/obstruction syndromes |
US10945787B2 (en) | 2012-10-29 | 2021-03-16 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US10952760B2 (en) | 2011-03-09 | 2021-03-23 | Neuravi Limited | Clot retrieval device for removing a clot from a blood vessel |
US10959941B2 (en) | 2014-05-29 | 2021-03-30 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US11007008B2 (en) | 2011-04-22 | 2021-05-18 | Ablative Solutions, Inc. | Methods of ablating tissue using a catheter injection system |
US11065140B2 (en) * | 2019-01-08 | 2021-07-20 | Covidien Lp | Rotatable stent delivery apparatus to cover access site |
US11103264B2 (en) | 2013-03-14 | 2021-08-31 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
US11147572B2 (en) | 2016-09-06 | 2021-10-19 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US11246612B2 (en) | 2010-10-22 | 2022-02-15 | Neuravi Limited | Clot engagement and removal system |
US11253278B2 (en) | 2014-11-26 | 2022-02-22 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US11259824B2 (en) | 2011-03-09 | 2022-03-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US11363951B2 (en) | 2011-09-13 | 2022-06-21 | Glaukos Corporation | Intraocular physiological sensor |
CN114652487A (en) * | 2020-12-23 | 2022-06-24 | 深圳市先健畅通医疗有限公司 | Support frame |
US11395669B2 (en) | 2020-06-23 | 2022-07-26 | Neuravi Limited | Clot retrieval device with flexible collapsible frame |
US11406416B2 (en) | 2018-10-02 | 2022-08-09 | Neuravi Limited | Joint assembly for vasculature obstruction capture device |
US11439418B2 (en) | 2020-06-23 | 2022-09-13 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11517340B2 (en) | 2019-12-03 | 2022-12-06 | Neuravi Limited | Stentriever devices for removing an occlusive clot from a vessel and methods thereof |
US11529157B2 (en) | 2008-07-22 | 2022-12-20 | Neuravi Limited | Clot capture systems and associated methods |
US11547427B2 (en) | 2013-03-14 | 2023-01-10 | Neuravi Limited | Clot retrieval devices |
US11712231B2 (en) | 2019-10-29 | 2023-08-01 | Neuravi Limited | Proximal locking assembly design for dual stent mechanical thrombectomy device |
US11712256B2 (en) | 2014-11-26 | 2023-08-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US11717308B2 (en) | 2020-04-17 | 2023-08-08 | Neuravi Limited | Clot retrieval device for removing heterogeneous clots from a blood vessel |
US11730501B2 (en) | 2020-04-17 | 2023-08-22 | Neuravi Limited | Floating clot retrieval device for removing clots from a blood vessel |
US11737771B2 (en) | 2020-06-18 | 2023-08-29 | Neuravi Limited | Dual channel thrombectomy device |
US11857210B2 (en) | 2014-11-26 | 2024-01-02 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11864781B2 (en) | 2020-09-23 | 2024-01-09 | Neuravi Limited | Rotating frame thrombectomy device |
US11871946B2 (en) | 2020-04-17 | 2024-01-16 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US11937837B2 (en) | 2020-12-29 | 2024-03-26 | Neuravi Limited | Fibrin rich / soft clot mechanical thrombectomy device |
US11937836B2 (en) | 2020-06-22 | 2024-03-26 | Neuravi Limited | Clot retrieval system with expandable clot engaging framework |
US11974764B2 (en) | 2021-06-04 | 2024-05-07 | Neuravi Limited | Self-orienting rotating stentriever pinching cells |
US12029442B2 (en) | 2021-01-14 | 2024-07-09 | Neuravi Limited | Systems and methods for a dual elongated member clot retrieval apparatus |
US12064130B2 (en) | 2021-03-18 | 2024-08-20 | Neuravi Limited | Vascular obstruction retrieval device having sliding cages pinch mechanism |
US12076037B2 (en) | 2011-03-09 | 2024-09-03 | Neuravi Limited | Systems and methods to restore perfusion to a vessel |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743251B1 (en) * | 2000-11-15 | 2004-06-01 | Scimed Life Systems, Inc. | Implantable devices with polymeric detachment junction |
US7572288B2 (en) * | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
WO2005094725A1 (en) | 2004-03-31 | 2005-10-13 | Merlin Md Pte Ltd | A method for treating aneurysms |
US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
WO2006055052A2 (en) * | 2004-07-19 | 2006-05-26 | Michael Gertner | Methods and devices for chronic embolic protection |
US7632304B2 (en) * | 2005-09-07 | 2009-12-15 | Rbkpark Llc | Coronary stent |
US9233012B2 (en) | 2005-09-07 | 2016-01-12 | RBKPark, LLC | Medical stent |
CA2642250A1 (en) * | 2006-02-13 | 2007-08-23 | Merlin Md Pte Ltd | Endovascular device with membrane |
US8454681B2 (en) * | 2006-09-13 | 2013-06-04 | Boston Scientific Scimed, Inc. | Bifurcation delivery systems and methods |
US20110160833A1 (en) * | 2007-07-11 | 2011-06-30 | Carlos Gonzalez | Implantable graft assembly |
US8956475B2 (en) | 2007-12-11 | 2015-02-17 | Howard Riina | Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen |
US8728141B2 (en) * | 2007-12-11 | 2014-05-20 | Cornell University | Method and apparatus for sealing an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while maintaining substantially normal flow through the body lumen |
EP2389141B1 (en) | 2009-01-22 | 2018-12-26 | Cornell University | Apparatus for restricting flow through the wall of a lumen |
GB2469824B (en) * | 2009-04-28 | 2011-08-03 | Cook William Europ | Introducer assembly and method of manufacturing an introducer assembly |
US10039534B2 (en) | 2010-02-26 | 2018-08-07 | ProMed, Inc. | Apparatus for vessel access closure |
EP2538848A2 (en) * | 2010-02-26 | 2013-01-02 | Promed, Inc. | System and method for vessel access closure |
US8920486B2 (en) | 2010-05-18 | 2014-12-30 | RBKPark, LLC | Medical device |
EP2763601B1 (en) | 2011-10-07 | 2020-03-25 | Cornell University | Apparatus for restricting flow through an opening in a body lumen while maintaining normal flow |
US10987208B2 (en) | 2012-04-06 | 2021-04-27 | Merlin Md Pte Ltd. | Devices and methods for treating an aneurysm |
US20150327868A1 (en) * | 2014-05-13 | 2015-11-19 | Ndi Tip Teknolojileri Anonim Sirketi | Retractable and rapid disconnect, floating diameter embolic coil product and delivery system |
GB201622215D0 (en) | 2016-12-23 | 2017-02-08 | Tonkin Liu Stents Ltd | Expanding device |
DE102018000966A1 (en) * | 2018-02-07 | 2019-08-22 | Universität Zu Köln | Neuralhülle |
FR3137558A1 (en) * | 2022-07-07 | 2024-01-12 | Dianosic | Implant and assembly for medical use for the introduction of such an implant into a cavity of a human or animal body |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041126A (en) * | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5135536A (en) | 1991-02-05 | 1992-08-04 | Cordis Corporation | Endovascular stent and method |
US5192307A (en) | 1987-12-08 | 1993-03-09 | Wall W Henry | Angioplasty stent |
US5259366A (en) * | 1992-11-03 | 1993-11-09 | Boris Reydel | Method of using a catheter-sleeve assembly for an endoscope |
US5263964A (en) * | 1992-05-06 | 1993-11-23 | Coil Partners Ltd. | Coaxial traction detachment apparatus and method |
US5314444A (en) | 1987-03-13 | 1994-05-24 | Cook Incorporated | Endovascular stent and delivery system |
US5342387A (en) | 1992-06-18 | 1994-08-30 | American Biomed, Inc. | Artificial support for a blood vessel |
US5354309A (en) | 1991-10-11 | 1994-10-11 | Angiomed Ag | Apparatus for widening a stenosis in a body cavity |
US5443500A (en) | 1989-01-26 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US5540712A (en) * | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5643314A (en) | 1995-11-13 | 1997-07-01 | Navius Corporation | Self-expanding stent |
US5702419A (en) * | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
US5772668A (en) * | 1992-06-18 | 1998-06-30 | American Biomed, Inc. | Apparatus for placing an endoprosthesis |
US5776142A (en) * | 1996-12-19 | 1998-07-07 | Medtronic, Inc. | Controllable stent delivery system and method |
WO1998039055A1 (en) | 1997-03-07 | 1998-09-11 | Micro Therapeutics, Inc. | Hoop stent |
WO1998050102A1 (en) | 1997-05-05 | 1998-11-12 | Micro Therapeutics, Inc. | Wire frame partial flow obstruction device for aneurysm treatment |
WO1998049983A1 (en) | 1997-05-02 | 1998-11-12 | Micro Therapeutics, Inc. | Expandable stent apparatus and method |
US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US5989230A (en) * | 1996-01-11 | 1999-11-23 | Essex Technology, Inc. | Rotate to advance catheterization system |
-
1999
- 1999-02-16 US US09/250,710 patent/US6231597B1/en not_active Expired - Fee Related
-
2000
- 2000-02-11 WO PCT/US2000/003662 patent/WO2000048517A1/en active Application Filing
- 2000-02-11 AU AU29929/00A patent/AU2992900A/en not_active Abandoned
-
2001
- 2001-03-22 US US09/816,952 patent/US20010012961A1/en not_active Abandoned
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041126A (en) * | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
US5314444A (en) | 1987-03-13 | 1994-05-24 | Cook Incorporated | Endovascular stent and delivery system |
US5192307A (en) | 1987-12-08 | 1993-03-09 | Wall W Henry | Angioplasty stent |
US5443500A (en) | 1989-01-26 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5135536A (en) | 1991-02-05 | 1992-08-04 | Cordis Corporation | Endovascular stent and method |
US5354309A (en) | 1991-10-11 | 1994-10-11 | Angiomed Ag | Apparatus for widening a stenosis in a body cavity |
US5540712A (en) * | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5263964A (en) * | 1992-05-06 | 1993-11-23 | Coil Partners Ltd. | Coaxial traction detachment apparatus and method |
US5772668A (en) * | 1992-06-18 | 1998-06-30 | American Biomed, Inc. | Apparatus for placing an endoprosthesis |
US5342387A (en) | 1992-06-18 | 1994-08-30 | American Biomed, Inc. | Artificial support for a blood vessel |
US5607445A (en) * | 1992-06-18 | 1997-03-04 | American Biomed, Inc. | Stent for supporting a blood vessel |
US5259366A (en) * | 1992-11-03 | 1993-11-09 | Boris Reydel | Method of using a catheter-sleeve assembly for an endoscope |
US5702419A (en) * | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
US5643314A (en) | 1995-11-13 | 1997-07-01 | Navius Corporation | Self-expanding stent |
US5989230A (en) * | 1996-01-11 | 1999-11-23 | Essex Technology, Inc. | Rotate to advance catheterization system |
US5776142A (en) * | 1996-12-19 | 1998-07-07 | Medtronic, Inc. | Controllable stent delivery system and method |
WO1998039055A1 (en) | 1997-03-07 | 1998-09-11 | Micro Therapeutics, Inc. | Hoop stent |
US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
WO1998049983A1 (en) | 1997-05-02 | 1998-11-12 | Micro Therapeutics, Inc. | Expandable stent apparatus and method |
WO1998050102A1 (en) | 1997-05-05 | 1998-11-12 | Micro Therapeutics, Inc. | Wire frame partial flow obstruction device for aneurysm treatment |
Non-Patent Citations (2)
Title |
---|
Ajay K. Wakhloo, et al., "Self-Expanding and Balloon-Expandable Stents in the Treatment of Carotid Aneurysms: An Experimental Study in a Canine Model", vol. 15, pp. 493-502, American Journal of Neuroradiology, Mar., 1994. |
Baruch B. Lieber, et al., "Alteration of Hemodynamics in Aneurysm Models by Stenting: Influence of Stent Porosity", vol. 25, pp. 460-469, Annals of Biomedical Engineering, 1997. |
Cited By (400)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783734B1 (en) * | 1997-06-27 | 2004-08-31 | The United States Of America As Represented By The Department Of Health And Human Services | Convex geometry adhesive film system for laser capture microdissection |
US6685735B1 (en) * | 1998-03-30 | 2004-02-03 | Endovascular Technologies, Inc. | Syent/graft deployment catheter with a stent/graft attachment mechanism |
US6613074B1 (en) * | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
US6827700B2 (en) | 1999-04-26 | 2004-12-07 | Gmp Vision Solutions, Inc. | Shunt device and method for treating glaucoma |
US20110196281A1 (en) * | 1999-04-26 | 2011-08-11 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US20050090807A1 (en) * | 1999-04-26 | 2005-04-28 | Gmp Vision Solutions, Inc. | Shunt device and method for treating glaucoma |
US9492320B2 (en) | 1999-04-26 | 2016-11-15 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US20050090806A1 (en) * | 1999-04-26 | 2005-04-28 | Gmp Vision Solutions Inc. | Shunt device and method for treating glaucoma |
US20050119601A9 (en) * | 1999-04-26 | 2005-06-02 | Lynch Mary G. | Shunt device and method for treating glaucoma |
US20030055372A1 (en) * | 1999-04-26 | 2003-03-20 | Lynch Mary G. | Shunt device and method for treating glaucoma |
US8771217B2 (en) | 1999-04-26 | 2014-07-08 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US6626858B2 (en) | 1999-04-26 | 2003-09-30 | Gmp Vision Solutions, Inc. | Shunt device and method for treating glaucoma |
US6827699B2 (en) | 1999-04-26 | 2004-12-07 | Gmp Vision Solutions, Inc. | Shunt device and method for treating glaucoma |
US8388568B2 (en) | 1999-04-26 | 2013-03-05 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US20100004580A1 (en) * | 1999-04-26 | 2010-01-07 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US20030236484A1 (en) * | 1999-04-26 | 2003-12-25 | Gmp Vision Solutions, Inc. | Inflatable device and method for treating glaucoma |
US6783544B2 (en) | 1999-04-26 | 2004-08-31 | Gmp Vision Solutions, Inc. | Stent device and method for treating glaucoma |
US10568762B2 (en) | 1999-04-26 | 2020-02-25 | Glaukos Corporation | Stent for treating ocular disorders |
US7850637B2 (en) | 1999-04-26 | 2010-12-14 | Glaukos Corporation | Shunt device and method for treating glaucoma |
US8152752B2 (en) | 1999-04-26 | 2012-04-10 | Glaukos Corporation | Shunt device and method for treating glaucoma |
US10492950B2 (en) | 1999-04-26 | 2019-12-03 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US9827143B2 (en) | 1999-04-26 | 2017-11-28 | Glaukos Corporation | Shunt device and method for treating ocular disorders |
US20040034429A1 (en) * | 1999-08-18 | 2004-02-19 | Lambrecht Gregg H, | Anchored anulus method |
US8409284B2 (en) | 1999-08-18 | 2013-04-02 | Intrinsic Therapeutics, Inc. | Methods of repairing herniated segments in the disc |
US8002836B2 (en) | 1999-08-18 | 2011-08-23 | Intrinsic Therapeutics, Inc. | Method for the treatment of the intervertebral disc anulus |
US8021425B2 (en) | 1999-08-18 | 2011-09-20 | Intrinsic Therapeutics, Inc. | Versatile method of repairing an intervertebral disc |
US7959679B2 (en) | 1999-08-18 | 2011-06-14 | Intrinsic Therapeutics, Inc. | Intervertebral anulus and nucleus augmentation |
US8025698B2 (en) | 1999-08-18 | 2011-09-27 | Intrinsic Therapeutics, Inc. | Method of rehabilitating an anulus fibrosus |
US7879097B2 (en) | 1999-08-18 | 2011-02-01 | Intrinsic Therapeutics, Inc. | Method of performing a procedure within a disc |
US8231678B2 (en) | 1999-08-18 | 2012-07-31 | Intrinsic Therapeutics, Inc. | Method of treating a herniated disc |
US7867278B2 (en) | 1999-08-18 | 2011-01-11 | Intrinsic Therapeutics, Inc. | Intervertebral disc anulus implant |
US7749275B2 (en) | 1999-08-18 | 2010-07-06 | Intrinsic Therapeutics, Inc. | Method of reducing spinal implant migration |
US7717961B2 (en) | 1999-08-18 | 2010-05-18 | Intrinsic Therapeutics, Inc. | Apparatus delivery in an intervertebral disc |
US7658765B2 (en) | 1999-08-18 | 2010-02-09 | Intrinsic Therapeutics, Inc. | Resilient intervertebral disc implant |
US8257437B2 (en) | 1999-08-18 | 2012-09-04 | Intrinsic Therapeutics, Inc. | Methods of intervertebral disc augmentation |
US7998213B2 (en) | 1999-08-18 | 2011-08-16 | Intrinsic Therapeutics, Inc. | Intervertebral disc herniation repair |
US9333087B2 (en) | 1999-08-18 | 2016-05-10 | Intrinsic Therapeutics, Inc. | Herniated disc repair |
US7563282B2 (en) | 1999-08-18 | 2009-07-21 | Intrinsic Therapeutics, Inc. | Method of supporting nucleus pulposus |
US7553329B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Stabilized intervertebral disc barrier |
US7553330B2 (en) | 1999-08-18 | 2009-06-30 | Intrinsic Therapeutics, Inc. | Methods of reinforcing an intervertebral disc annulus |
US7524333B2 (en) | 1999-08-18 | 2009-04-28 | Intrinsic Therapeutics, Inc. | Method of anchoring an implant in an intervertebral disc |
US20050038519A1 (en) * | 1999-08-18 | 2005-02-17 | Lambrecht Gregory H. | Method of reducing spinal implant migration |
US7513911B2 (en) | 1999-08-18 | 2009-04-07 | Intrinsic Therapeutics, Inc. | Method of implanting dynamically stable spinal implant |
US7507243B2 (en) | 1999-08-18 | 2009-03-24 | Gregory Lambrecht | Devices and method for augmenting a vertebral disc |
US20060217812A1 (en) * | 1999-08-18 | 2006-09-28 | Lambrecht Greg H | Method of anchoring an implant in an intervertebral disc |
US9706947B2 (en) | 1999-08-18 | 2017-07-18 | Intrinsic Therapeutics, Inc. | Method of performing an anchor implantation procedure within a disc |
US7198047B2 (en) | 1999-08-18 | 2007-04-03 | Intrinsic Therapeutics, Inc. | Anchored anulus method |
US6599315B2 (en) | 1999-12-15 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Stent and stent delivery assembly and method of use |
US8808219B2 (en) | 2000-04-14 | 2014-08-19 | Glaukos Corporation | Implant delivery device and methods thereof for treatment of ocular disorders |
US8273050B2 (en) | 2000-04-14 | 2012-09-25 | Glaukos Corporation | Ocular implant with anchor and therapeutic agent |
US20100056979A1 (en) * | 2000-04-14 | 2010-03-04 | Glaukos Corporation | Implantable ocular pump to reduce intraocular pressure |
US8814820B2 (en) | 2000-04-14 | 2014-08-26 | Glaukos Corporation | Ocular implant with therapeutic agent and methods thereof |
US20050209550A1 (en) * | 2000-04-14 | 2005-09-22 | Bergheim Olav B | Method of treating glaucoma using an implant having a uniform diameter between the anterior chamber and Schlemm's canal |
US20050209549A1 (en) * | 2000-04-14 | 2005-09-22 | Bergheim Olav B | Glaucoma implant with multiple openings |
US6955656B2 (en) | 2000-04-14 | 2005-10-18 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US20040254519A1 (en) * | 2000-04-14 | 2004-12-16 | Hosheng Tu | Glaucoma treatment device |
US9066782B2 (en) | 2000-04-14 | 2015-06-30 | Dose Medical Corporation | Ocular implant with therapeutic agents and methods thereof |
US20030187385A1 (en) * | 2000-04-14 | 2003-10-02 | Bergheim Olav B. | Implant with anchor |
US6638239B1 (en) | 2000-04-14 | 2003-10-28 | Glaukos Corporation | Apparatus and method for treating glaucoma |
US20050277864A1 (en) * | 2000-04-14 | 2005-12-15 | David Haffner | Injectable gel implant for glaucoma treatment |
US7708711B2 (en) | 2000-04-14 | 2010-05-04 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
US8348877B2 (en) | 2000-04-14 | 2013-01-08 | Dose Medical Corporation | Ocular implant with therapeutic agents and methods thereof |
US8333742B2 (en) | 2000-04-14 | 2012-12-18 | Glaukos Corporation | Method of delivering an implant for treating an ocular disorder |
US20040127843A1 (en) * | 2000-04-14 | 2004-07-01 | Hosheng Tu | Glaucoma implant with therapeutic agents |
US20040249333A1 (en) * | 2000-04-14 | 2004-12-09 | Bergheim Olav B. | Glaucoma implant with bi-directional flow |
US8801648B2 (en) | 2000-04-14 | 2014-08-12 | Glaukos Corporation | Ocular implant with anchor and methods thereof |
US20090137983A1 (en) * | 2000-04-14 | 2009-05-28 | Glaukos Corporation | Implant delivery device and methods thereof for treatment of ocular disorders |
US20040210185A1 (en) * | 2000-04-14 | 2004-10-21 | Hosheng Tu | Glaucoma implant kit |
US20100234790A1 (en) * | 2000-04-14 | 2010-09-16 | Glaukos Corporation | Ocular implant with therapeutic agents and methods thereof |
US20050049578A1 (en) * | 2000-04-14 | 2005-03-03 | Hosheng Tu | Implantable ocular pump to reduce intraocular pressure |
US9993368B2 (en) | 2000-04-14 | 2018-06-12 | Glaukos Corporation | System and method for treating an ocular disorder |
US9789001B2 (en) | 2000-04-14 | 2017-10-17 | Dose Medical Corporation | Ocular implant with therapeutic agents and methods thereof |
US6780164B2 (en) | 2000-04-14 | 2004-08-24 | Glaukos Corporation | L-shaped implant with bi-directional flow |
US20100010414A1 (en) * | 2000-04-14 | 2010-01-14 | Glaukos Corporation | Method of delivering an implant for treating an ocular disorder |
US7867205B2 (en) | 2000-04-14 | 2011-01-11 | Glaukos Corporation | Method of delivering an implant for treating an ocular disorder |
US20080234624A2 (en) * | 2000-04-14 | 2008-09-25 | Glaukos Corporation | Ocular implant with anchor and therapeutic agent |
US7297130B2 (en) | 2000-04-14 | 2007-11-20 | Glaukos Corporation | Implant with anchor |
US20070282245A1 (en) * | 2000-04-14 | 2007-12-06 | Glaukos Corporation | Glaucoma implant with valve |
US10485702B2 (en) | 2000-04-14 | 2019-11-26 | Glaukos Corporation | System and method for treating an ocular disorder |
US20040111050A1 (en) * | 2000-04-14 | 2004-06-10 | Gregory Smedley | Implantable ocular pump to reduce intraocular pressure |
US20100324534A1 (en) * | 2000-05-09 | 2010-12-23 | Arthrocare Corporation | Nasal packing device |
US8137375B2 (en) | 2000-05-09 | 2012-03-20 | Arthrocare Corporation | Nasal packing device |
US7799048B2 (en) | 2000-05-09 | 2010-09-21 | Arthrocare Corporation | Nasal packing device |
US20030105483A1 (en) * | 2000-05-09 | 2003-06-05 | Hudson John Overton | Nasal packing device |
US20050096732A1 (en) * | 2000-08-18 | 2005-05-05 | Marotta Thomas R. | Endovascular prosthesis |
US7959662B2 (en) | 2000-11-17 | 2011-06-14 | Raimund Erbel | Endovascular prosthesis |
US20040098091A1 (en) * | 2000-11-17 | 2004-05-20 | Raimund Erbel | Endovascular prosthesis |
US20040073299A1 (en) * | 2000-12-16 | 2004-04-15 | Hudson John Overton | Hemostatic device |
US20020143284A1 (en) * | 2001-04-03 | 2002-10-03 | Hosheng Tu | Drug-releasing trabecular implant for glaucoma treatment |
US9572963B2 (en) | 2001-04-07 | 2017-02-21 | Glaukos Corporation | Ocular disorder treatment methods and systems |
US10828473B2 (en) | 2001-04-07 | 2020-11-10 | Glaukos Corporation | Ocular implant delivery system and methods thereof |
US9987472B2 (en) | 2001-04-07 | 2018-06-05 | Glaukos Corporation | Ocular implant delivery systems |
US20070112292A1 (en) * | 2001-04-07 | 2007-05-17 | Hosheng Tu | Glaucoma stent and methods thereof for glaucoma treatment |
US7857782B2 (en) | 2001-04-07 | 2010-12-28 | Glaukos Corporation | Ocular implant delivery system and method thereof |
US8075511B2 (en) | 2001-04-07 | 2011-12-13 | Glaukos Corporation | System for treating ocular disorders and methods thereof |
US8118768B2 (en) | 2001-04-07 | 2012-02-21 | Dose Medical Corporation | Drug eluting ocular implant with anchor and methods thereof |
US8062244B2 (en) | 2001-04-07 | 2011-11-22 | Glaukos Corporation | Self-trephining implant and methods thereof for treatment of ocular disorders |
US7135009B2 (en) | 2001-04-07 | 2006-11-14 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US20090138022A1 (en) * | 2001-04-07 | 2009-05-28 | Glaukos Corporation | Ocular implant delivery system and method thereof |
US9155654B2 (en) | 2001-04-07 | 2015-10-13 | Glaukos Corporation | Ocular system with anchoring implant and therapeutic agent |
US8579846B2 (en) | 2001-04-07 | 2013-11-12 | Glaukos Corporation | Ocular implant systems |
US10406029B2 (en) | 2001-04-07 | 2019-09-10 | Glaukos Corporation | Ocular system with anchoring implant and therapeutic agent |
US7563241B2 (en) | 2001-04-07 | 2009-07-21 | Glaukos Corporation | Implant and methods thereof for treatment of ocular disorders |
US20020188308A1 (en) * | 2001-04-07 | 2002-12-12 | Hosheng Tu | Glaucoma stent and methods thereof for glaucoma treatment |
US8142364B2 (en) | 2001-05-02 | 2012-03-27 | Dose Medical Corporation | Method of monitoring intraocular pressure and treating an ocular disorder |
US6981958B1 (en) | 2001-05-02 | 2006-01-03 | Glaukos Corporation | Implant with pressure sensor for glaucoma treatment |
US20090076436A2 (en) * | 2001-05-02 | 2009-03-19 | Glaukos Corporation | Ocular implants with deployable structure |
US20050192527A1 (en) * | 2001-05-02 | 2005-09-01 | Morteza Gharib | Glaucoma implant with extending members |
US6666841B2 (en) | 2001-05-02 | 2003-12-23 | Glaukos Corporation | Bifurcatable trabecular shunt for glaucoma treatment |
US20050119636A1 (en) * | 2001-05-02 | 2005-06-02 | David Haffner | Implant with intraocular pressure sensor for glaucoma treatment |
US7678065B2 (en) | 2001-05-02 | 2010-03-16 | Glaukos Corporation | Implant with intraocular pressure sensor for glaucoma treatment |
US8337445B2 (en) | 2001-05-03 | 2012-12-25 | Glaukos Corporation | Ocular implant with double anchor mechanism |
US20020169130A1 (en) * | 2001-05-03 | 2002-11-14 | Hosheng Tu | Medical device and methods of use for glaucoma treatment |
US7094225B2 (en) | 2001-05-03 | 2006-08-22 | Glaukos Corporation | Medical device and methods of use of glaucoma treatment |
US20080015488A1 (en) * | 2001-05-03 | 2008-01-17 | Glaukos Corporation | Glaucoma implant with double anchor mechanism |
US7273475B2 (en) | 2001-05-03 | 2007-09-25 | Glaukos Corporation | Medical device and methods of use for glaucoma treatment |
US6607539B1 (en) * | 2001-05-18 | 2003-08-19 | Endovascular Technologies, Inc. | Electric endovascular implant depolyment system |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8870909B2 (en) * | 2001-07-20 | 2014-10-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US20120289993A1 (en) * | 2001-07-20 | 2012-11-15 | Cox Brian J | Aneurysm Treatment Device And Method Of Use |
US20040186562A1 (en) * | 2001-07-20 | 2004-09-23 | Cox Brian J. | Aneurysm treatment device and method of use |
US9622753B2 (en) | 2001-07-20 | 2017-04-18 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8252040B2 (en) * | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US20040050392A1 (en) * | 2001-08-28 | 2004-03-18 | Hosheng Tu | Glaucoma stent for treating glaucoma and methods of use |
US20060241749A1 (en) * | 2001-08-28 | 2006-10-26 | Hosheng Tu | Glaucoma stent system |
US20070010827A1 (en) * | 2001-08-28 | 2007-01-11 | Hosheng Tu | Glaucoma stent system |
US7331984B2 (en) | 2001-08-28 | 2008-02-19 | Glaukos Corporation | Glaucoma stent for treating glaucoma and methods of use |
US10285856B2 (en) | 2001-08-28 | 2019-05-14 | Glaukos Corporation | Implant delivery system and methods thereof for treating ocular disorders |
US7879079B2 (en) | 2001-08-28 | 2011-02-01 | Glaukos Corporation | Implant delivery system and methods thereof for treating ocular disorders |
US9561131B2 (en) | 2001-08-28 | 2017-02-07 | Glaukos Corporation | Implant delivery system and methods thereof for treating ocular disorders |
US20030097151A1 (en) * | 2001-10-25 | 2003-05-22 | Smedley Gregory T. | Apparatus and mitochondrial treatment for glaucoma |
US20030088260A1 (en) * | 2001-11-08 | 2003-05-08 | Smedley Gregory T. | Combined treatment for cataract and glaucoma treatment |
US7163543B2 (en) | 2001-11-08 | 2007-01-16 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US20030171801A1 (en) * | 2002-03-06 | 2003-09-11 | Brian Bates | Partially covered intraluminal support device |
US7186232B1 (en) | 2002-03-07 | 2007-03-06 | Glaukoa Corporation | Fluid infusion methods for glaucoma treatment |
US9220632B2 (en) | 2002-03-07 | 2015-12-29 | Glaukos Corporation | Fluid infusion methods for ocular disorder treatment |
US8617094B2 (en) | 2002-03-07 | 2013-12-31 | Glaukos Corporation | Fluid infusion methods for glaucoma treatment |
US20070118147A1 (en) * | 2002-03-15 | 2007-05-24 | Smedley Gregory T | Combined treatment for cataract and glaucoma treatment |
US8882781B2 (en) | 2002-03-15 | 2014-11-11 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US7951155B2 (en) * | 2002-03-15 | 2011-05-31 | Glaukos Corporation | Combined treatment for cataract and glaucoma treatment |
US7431710B2 (en) | 2002-04-08 | 2008-10-07 | Glaukos Corporation | Ocular implants with anchors and methods thereof |
US10485701B2 (en) | 2002-04-08 | 2019-11-26 | Glaukos Corporation | Devices and methods for glaucoma treatment |
US20040102729A1 (en) * | 2002-04-08 | 2004-05-27 | David Haffner | Devices and methods for glaucoma treatment |
US9301875B2 (en) | 2002-04-08 | 2016-04-05 | Glaukos Corporation | Ocular disorder treatment implants with multiple opening |
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US20040147870A1 (en) * | 2002-04-08 | 2004-07-29 | Burns Thomas W. | Glaucoma treatment kit |
US7879001B2 (en) | 2002-04-08 | 2011-02-01 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
US20050266047A1 (en) * | 2002-04-08 | 2005-12-01 | Hosheng Tu | Injectable glaucoma implants with multiple openings |
US9597230B2 (en) | 2002-04-08 | 2017-03-21 | Glaukos Corporation | Devices and methods for glaucoma treatment |
US20050271704A1 (en) * | 2002-04-08 | 2005-12-08 | Hosheng Tu | Injectable glaucoma implants with multiple openings |
US20040024345A1 (en) * | 2002-04-19 | 2004-02-05 | Morteza Gharib | Glaucoma implant with valveless flow bias |
US20090292352A1 (en) * | 2002-06-27 | 2009-11-26 | Boston Scientific Scimed, Inc. | Methods of making medical devices |
US8007459B2 (en) | 2002-09-21 | 2011-08-30 | Glaukos Corporation | Ocular implant with anchoring mechanism and multiple outlets |
US7488303B1 (en) | 2002-09-21 | 2009-02-10 | Glaukos Corporation | Ocular implant with anchor and multiple openings |
US7201775B2 (en) | 2002-09-24 | 2007-04-10 | Bogomir Gorensek | Stabilizing device for intervertebral disc, and methods thereof |
US20040230305A1 (en) * | 2002-09-24 | 2004-11-18 | Bogomir Gorensek | Stabilizing device for intervertebral disc, and methods thereof |
US20060099191A1 (en) * | 2002-10-16 | 2006-05-11 | The General Hospital Corporation | Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
WO2004034984A3 (en) * | 2002-10-16 | 2004-07-01 | Gen Hospital Corp | Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
WO2004034984A2 (en) * | 2002-10-16 | 2004-04-29 | The General Hospital Corporation | Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
US6899729B1 (en) * | 2002-12-18 | 2005-05-31 | Advanced Cardiovascular Systems, Inc. | Stent for treating vulnerable plaque |
US8016869B2 (en) | 2003-03-26 | 2011-09-13 | Biosensors International Group, Ltd. | Guidewire-less stent delivery methods |
US20040267348A1 (en) * | 2003-04-11 | 2004-12-30 | Gunderson Richard C. | Medical device delivery systems |
US20040225344A1 (en) * | 2003-04-23 | 2004-11-11 | Hoffa Andrew K. | Devices, kits and methods for placing multiple intraluminal medical devices in a body vessel |
US7727241B2 (en) | 2003-06-20 | 2010-06-01 | Intrinsic Therapeutics, Inc. | Device for delivering an implant through an annular defect in an intervertebral disc |
US7500978B2 (en) | 2003-06-20 | 2009-03-10 | Intrinsic Therapeutics, Inc. | Method for delivering and positioning implants in the intervertebral disc environment |
US7727268B2 (en) * | 2003-07-17 | 2010-06-01 | Medtronic Vascular, Inc. | Methods and devices for placing a fistula device in fluid communication with a target vessel |
US20050033401A1 (en) * | 2003-07-17 | 2005-02-10 | Brendan Cunniffe | Methods and devices for placing a fistula device in fluid communication with a target vessel |
US20050049666A1 (en) * | 2003-08-26 | 2005-03-03 | Chien Thomas Yung-Hui | Stent delivery system |
US20050125051A1 (en) * | 2003-12-05 | 2005-06-09 | Scimed Life Systems, Inc. | Detachable segment stent |
US8157855B2 (en) | 2003-12-05 | 2012-04-17 | Boston Scientific Scimed, Inc. | Detachable segment stent |
US8475518B2 (en) | 2003-12-22 | 2013-07-02 | Advanced Cardiovascular Systems, Inc. | Stent with anchors to prevent vulnerable plaque rupture during deployment |
US7258697B1 (en) | 2003-12-22 | 2007-08-21 | Advanced Cardiovascular Systems, Inc. | Stent with anchors to prevent vulnerable plaque rupture during deployment |
US20050250788A1 (en) * | 2004-01-30 | 2005-11-10 | Hosheng Tu | Aqueous outflow enhancement with vasodilated aqueous cavity |
US20050240255A1 (en) * | 2004-04-23 | 2005-10-27 | Schaeffer Darin G | Carrier-Based Delivery System for Intraluminal Medical Devices |
US20060047297A1 (en) * | 2004-08-27 | 2006-03-02 | Case Brian C | Placement of multiple intraluminal medical devices within a body vessel |
US9050095B2 (en) | 2004-09-22 | 2015-06-09 | Covidien Lp | Medical implant |
US9198665B2 (en) | 2004-09-22 | 2015-12-01 | Covidien Lp | Micro-spiral implantation device |
US20090123914A1 (en) * | 2004-09-24 | 2009-05-14 | Ingeneus Inc. | Genomic Assay |
US10322018B2 (en) | 2005-05-25 | 2019-06-18 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10064747B2 (en) | 2005-05-25 | 2018-09-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9381104B2 (en) | 2005-05-25 | 2016-07-05 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9095343B2 (en) | 2005-05-25 | 2015-08-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9198666B2 (en) | 2005-05-25 | 2015-12-01 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9204983B2 (en) | 2005-05-25 | 2015-12-08 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US20100063531A1 (en) * | 2005-11-09 | 2010-03-11 | Merlin Md Pte Ltd. | Medical Device with Non-Circumferential Surface Portion |
US9307996B2 (en) * | 2005-12-13 | 2016-04-12 | DePuy Synthes Products, Inc. | Detachment actuator for use with medical device deployment systems |
US20090270877A1 (en) * | 2005-12-13 | 2009-10-29 | Johnson Kirk L | Detachment Actuator for Use With Medical Device Deployment Systems |
US11185354B2 (en) | 2005-12-28 | 2021-11-30 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems and methods |
US10470804B2 (en) | 2005-12-28 | 2019-11-12 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems and methods |
US9039741B2 (en) | 2005-12-28 | 2015-05-26 | Intrinsic Therapeutics, Inc. | Bone anchor systems |
US8114082B2 (en) | 2005-12-28 | 2012-02-14 | Intrinsic Therapeutics, Inc. | Anchoring system for disc repair |
US7972337B2 (en) | 2005-12-28 | 2011-07-05 | Intrinsic Therapeutics, Inc. | Devices and methods for bone anchoring |
US9610106B2 (en) | 2005-12-28 | 2017-04-04 | Intrinsic Therapeutics, Inc. | Bone anchor systems |
US8394146B2 (en) | 2005-12-28 | 2013-03-12 | Intrinsic Therapeutics, Inc. | Vertebral anchoring methods |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US20090069880A1 (en) * | 2006-02-03 | 2009-03-12 | Design & Performance - Cyprus Limited | Implantable graft assembly and aneurysm treatment |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8864790B2 (en) | 2006-04-17 | 2014-10-21 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8795321B2 (en) | 2006-04-17 | 2014-08-05 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8777978B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8795320B2 (en) | 2006-04-17 | 2014-08-05 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US20070293807A1 (en) * | 2006-05-01 | 2007-12-20 | Lynch Mary G | Dual drainage pathway shunt device and method for treating glaucoma |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US20080071353A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Scimed, Inc. | Endoprosthesis containing magnetic induction particles |
US20080071348A1 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Scimed, Inc. | Medical Devices |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US12186237B2 (en) | 2006-11-10 | 2025-01-07 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US10828195B2 (en) | 2006-11-10 | 2020-11-10 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US8506515B2 (en) | 2006-11-10 | 2013-08-13 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US9962290B2 (en) | 2006-11-10 | 2018-05-08 | Glaukos Corporation | Uveoscleral shunt and methods for implanting same |
US20080119943A1 (en) * | 2006-11-16 | 2008-05-22 | Armstrong Joseph R | Stent having flexibly connected adjacent stent elements |
US9622888B2 (en) | 2006-11-16 | 2017-04-18 | W. L. Gore & Associates, Inc. | Stent having flexibly connected adjacent stent elements |
US10456281B2 (en) | 2006-11-16 | 2019-10-29 | W.L. Gore & Associates, Inc. | Stent having flexibly connected adjacent stent elements |
US8187315B1 (en) | 2006-12-08 | 2012-05-29 | Cardica, Inc. | Partial stent for treatment of a vascular aneurysm |
US8715339B2 (en) | 2006-12-28 | 2014-05-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US20080172204A1 (en) * | 2007-01-15 | 2008-07-17 | Fujitsu Limited | Step counter and method of counting steps |
US8328860B2 (en) | 2007-03-13 | 2012-12-11 | Covidien Lp | Implant including a coil and a stretch-resistant member |
US8801747B2 (en) | 2007-03-13 | 2014-08-12 | Covidien Lp | Implant, a mandrel, and a method of forming an implant |
US9289215B2 (en) | 2007-03-13 | 2016-03-22 | Covidien Lp | Implant including a coil and a stretch-resistant member |
WO2008148014A2 (en) * | 2007-05-23 | 2008-12-04 | C.R. Bard, Inc. | Polymer coated stent |
WO2008148014A3 (en) * | 2007-05-23 | 2009-02-19 | Bard Inc C R | Polymer coated stent |
US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
US8361155B2 (en) | 2007-09-07 | 2013-01-29 | Intrinsic Therapeutics, Inc. | Soft tissue impaction methods |
US10076424B2 (en) | 2007-09-07 | 2018-09-18 | Intrinsic Therapeutics, Inc. | Impaction systems |
US9226832B2 (en) | 2007-09-07 | 2016-01-05 | Intrinsic Therapeutics, Inc. | Interbody fusion material retention methods |
US10716685B2 (en) | 2007-09-07 | 2020-07-21 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems |
US8323341B2 (en) | 2007-09-07 | 2012-12-04 | Intrinsic Therapeutics, Inc. | Impaction grafting for vertebral fusion |
US8454612B2 (en) | 2007-09-07 | 2013-06-04 | Intrinsic Therapeutics, Inc. | Method for vertebral endplate reconstruction |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8926688B2 (en) | 2008-01-11 | 2015-01-06 | W. L. Gore & Assoc. Inc. | Stent having adjacent elements connected by flexible webs |
US11865020B2 (en) | 2008-01-11 | 2024-01-09 | W. L. Gore & Associates, Inc. | Stent having adjacent elements connected by flexible webs |
US11103372B2 (en) | 2008-01-11 | 2021-08-31 | W. L. Gore & Associates, Inc. | Stent having adjacent elements connected by flexible webs |
US9943428B2 (en) | 2008-01-11 | 2018-04-17 | W. L. Gore & Associates, Inc. | Stent having adjacent elements connected by flexible webs |
US20090182413A1 (en) * | 2008-01-11 | 2009-07-16 | Burkart Dustin C | Stent having adjacent elements connected by flexible webs |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10610389B2 (en) | 2008-05-13 | 2020-04-07 | Covidien Lp | Braid implant delivery systems |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
US20090306765A1 (en) * | 2008-06-10 | 2009-12-10 | Boston Scientific Scimed, Inc. | Bioerodible Endoprosthesis |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US11529157B2 (en) | 2008-07-22 | 2022-12-20 | Neuravi Limited | Clot capture systems and associated methods |
US20110118826A1 (en) * | 2008-07-30 | 2011-05-19 | Boston Scientific Scimed. Inc. | Bioerodible Endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US20100106240A1 (en) * | 2008-10-20 | 2010-04-29 | IMDS, Inc. | Systems and Methods for Aneurysm Treatment and Vessel Occlusion |
US8470013B2 (en) | 2008-10-20 | 2013-06-25 | Imds Corporation | Systems and methods for aneurysm treatment and vessel occlusion |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US20100262216A1 (en) * | 2009-04-09 | 2010-10-14 | Medtronic Vascular, Inc. | Stent having a C-shaped body section for use in a bifurcation |
US9486344B2 (en) * | 2009-04-09 | 2016-11-08 | Medtronic Vascular, Inc. | Stent system with abutable C-shaped body sections for use in a bifurcated body vessel |
US20160000589A1 (en) * | 2009-04-09 | 2016-01-07 | Medtronic Vascular, Inc. | Stent System With Abutable C-Shaped Body Sections For Use in a Bifurcated Body Vessel |
US9427302B2 (en) * | 2009-04-09 | 2016-08-30 | Medtronic Vascular, Inc. | Stent having a C-shaped body section for use in a bifurcation |
WO2010123911A3 (en) * | 2009-04-22 | 2011-01-13 | Lake Region Medical, Inc. | Aneurysm treatment system, device and method |
CN102448380A (en) * | 2009-04-22 | 2012-05-09 | 湖区制造公司,商用名湖区医药 | Aneurysm treatment system, device and method |
US20100274276A1 (en) * | 2009-04-22 | 2010-10-28 | Ricky Chow | Aneurysm treatment system, device and method |
WO2010123911A2 (en) * | 2009-04-22 | 2010-10-28 | Lake Region Medical, Inc. | Aneurysm treatment system, device and method |
US11571291B2 (en) | 2009-05-01 | 2023-02-07 | Endologix Llc | Percutaneous method and device to treat dissections |
US9579103B2 (en) * | 2009-05-01 | 2017-02-28 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US20100280588A1 (en) * | 2009-05-01 | 2010-11-04 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US9572652B2 (en) | 2009-12-01 | 2017-02-21 | Altura Medical, Inc. | Modular endograft devices and associated systems and methods |
US20110160839A1 (en) * | 2009-12-29 | 2011-06-30 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8858613B2 (en) | 2010-09-20 | 2014-10-14 | Altura Medical, Inc. | Stent graft delivery systems and associated methods |
US11871949B2 (en) | 2010-10-22 | 2024-01-16 | Neuravi Limited | Clot engagement and removal system |
US11246612B2 (en) | 2010-10-22 | 2022-02-15 | Neuravi Limited | Clot engagement and removal system |
US11998223B2 (en) | 2011-03-09 | 2024-06-04 | Neuravi Limited | Clot retrieval device for removing a clot from a blood vessel |
US10952760B2 (en) | 2011-03-09 | 2021-03-23 | Neuravi Limited | Clot retrieval device for removing a clot from a blood vessel |
US11259824B2 (en) | 2011-03-09 | 2022-03-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US12059164B2 (en) | 2011-03-09 | 2024-08-13 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US12076037B2 (en) | 2011-03-09 | 2024-09-03 | Neuravi Limited | Systems and methods to restore perfusion to a vessel |
US10172663B2 (en) | 2011-04-22 | 2019-01-08 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US11007346B2 (en) | 2011-04-22 | 2021-05-18 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US9237925B2 (en) | 2011-04-22 | 2016-01-19 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US11964113B2 (en) | 2011-04-22 | 2024-04-23 | Ablative Solutions, Inc. | Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation |
US11717345B2 (en) | 2011-04-22 | 2023-08-08 | Ablative Solutions, Inc. | Methods of ablating tissue using a catheter injection system |
US11007008B2 (en) | 2011-04-22 | 2021-05-18 | Ablative Solutions, Inc. | Methods of ablating tissue using a catheter injection system |
US10058330B2 (en) | 2011-05-11 | 2018-08-28 | Microvention, Inc. | Device for occluding a lumen |
US10485951B2 (en) | 2011-08-24 | 2019-11-26 | Ablative Solutions, Inc. | Catheter systems and packaged kits for dual layer guide tubes |
US11752303B2 (en) | 2011-08-24 | 2023-09-12 | Ablative Solutions, Inc. | Catheter systems and packaged kits for dual layer guide tubes |
US9278196B2 (en) | 2011-08-24 | 2016-03-08 | Ablative Solutions, Inc. | Expandable catheter system for vessel wall injection and muscle and nerve fiber ablation |
US10576246B2 (en) | 2011-08-24 | 2020-03-03 | Ablative Solutions, Inc. | Intravascular fluid catheter with minimal internal fluid volume |
US11007329B2 (en) | 2011-08-24 | 2021-05-18 | Ablative Solutions, Inc. | Expandable catheter system for fluid injection into and deep to the wall of a blood vessel |
US10118004B2 (en) | 2011-08-24 | 2018-11-06 | Ablative Solutions, Inc. | Expandable catheter system for fluid injection into and deep to the wall of a blood vessel |
US11759608B2 (en) | 2011-08-24 | 2023-09-19 | Ablative Solutions, Inc. | Intravascular fluid catheter with minimal internal fluid volume |
US11363951B2 (en) | 2011-09-13 | 2022-06-21 | Glaukos Corporation | Intraocular physiological sensor |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US10335155B2 (en) * | 2011-11-30 | 2019-07-02 | Covidien Lp | Positioning and detaching implants |
US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
US10893868B2 (en) | 2012-01-20 | 2021-01-19 | Covidien Lp | Aneurysm treatment coils |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
US9173775B2 (en) | 2012-03-26 | 2015-11-03 | Glaukos Corporation | System for delivering multiple ocular implants |
US11944573B2 (en) | 2012-03-26 | 2024-04-02 | Glaukos Corporation | System and method for delivering multiple ocular implants |
US10271989B2 (en) | 2012-03-26 | 2019-04-30 | Glaukos Corporation | System and method for delivering multiple ocular implants |
US11197780B2 (en) | 2012-03-26 | 2021-12-14 | Glaukos Corporation | System and method for delivering multiple ocular implants |
US9877856B2 (en) | 2012-07-18 | 2018-01-30 | Covidien Lp | Methods and apparatus for luminal stenting |
US20140025154A1 (en) * | 2012-07-18 | 2014-01-23 | Tyco Healthcare Group Lp | Methods and apparatus for luminal stenting |
US9155647B2 (en) * | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US10285833B2 (en) | 2012-08-10 | 2019-05-14 | Lombard Medical Limited | Stent delivery systems and associated methods |
US10405912B2 (en) | 2012-10-29 | 2019-09-10 | Ablative Solutions, Inc. | Transvascular methods of treating extravascular tissue |
US12245790B2 (en) | 2012-10-29 | 2025-03-11 | Ablative Solutions, Inc. | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
US12156982B2 (en) | 2012-10-29 | 2024-12-03 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US9539047B2 (en) | 2012-10-29 | 2017-01-10 | Ablative Solutions, Inc. | Transvascular methods of treating extravascular tissue |
US10736656B2 (en) | 2012-10-29 | 2020-08-11 | Ablative Solutions | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
US9179962B2 (en) | 2012-10-29 | 2015-11-10 | Ablative Solutions, Inc. | Transvascular methods of treating extravascular tissue |
US11944373B2 (en) | 2012-10-29 | 2024-04-02 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US11980408B2 (en) | 2012-10-29 | 2024-05-14 | Ablative Solutions, Inc. | Transvascular methods of treating extravascular tissue |
US10226278B2 (en) | 2012-10-29 | 2019-03-12 | Ablative Solutions, Inc. | Method for painless renal denervation using a peri-vascular tissue ablation catheter with support structures |
US9526827B2 (en) | 2012-10-29 | 2016-12-27 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US10881458B2 (en) | 2012-10-29 | 2021-01-05 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US12053238B2 (en) | 2012-10-29 | 2024-08-06 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US10350392B2 (en) | 2012-10-29 | 2019-07-16 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US10945787B2 (en) | 2012-10-29 | 2021-03-16 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheters |
US11202889B2 (en) | 2012-10-29 | 2021-12-21 | Ablative Solutions, Inc. | Peri-vascular tissue ablation catheter with support structures |
US10849558B2 (en) | 2013-03-13 | 2020-12-01 | Glaukos Corporation | Intraocular physiological sensor |
US9730638B2 (en) | 2013-03-13 | 2017-08-15 | Glaukos Corporation | Intraocular physiological sensor |
US11871945B2 (en) | 2013-03-14 | 2024-01-16 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US10588648B2 (en) | 2013-03-14 | 2020-03-17 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11839392B2 (en) | 2013-03-14 | 2023-12-12 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11547427B2 (en) | 2013-03-14 | 2023-01-10 | Neuravi Limited | Clot retrieval devices |
US11103264B2 (en) | 2013-03-14 | 2021-08-31 | Neuravi Limited | Devices and methods for removal of acute blockages from blood vessels |
US20160113665A1 (en) * | 2013-03-14 | 2016-04-28 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11937835B2 (en) | 2013-03-14 | 2024-03-26 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US10675045B2 (en) * | 2013-03-14 | 2020-06-09 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US10610246B2 (en) | 2013-03-14 | 2020-04-07 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US10278717B2 (en) | 2013-03-14 | 2019-05-07 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US9592151B2 (en) | 2013-03-15 | 2017-03-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US9737426B2 (en) | 2013-03-15 | 2017-08-22 | Altura Medical, Inc. | Endograft device delivery systems and associated methods |
US10285853B2 (en) | 2013-03-15 | 2019-05-14 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US11559430B2 (en) | 2013-03-15 | 2023-01-24 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
US11523938B2 (en) | 2013-03-15 | 2022-12-13 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US10188551B2 (en) | 2013-03-15 | 2019-01-29 | Glaukos Corporation | Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US10881312B2 (en) | 2013-10-25 | 2021-01-05 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US10517666B2 (en) | 2013-10-25 | 2019-12-31 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US11751787B2 (en) | 2013-10-25 | 2023-09-12 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
US10420481B2 (en) | 2013-10-25 | 2019-09-24 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US9949652B2 (en) | 2013-10-25 | 2018-04-24 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US9931046B2 (en) | 2013-10-25 | 2018-04-03 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
US12239361B2 (en) | 2013-10-25 | 2025-03-04 | Ablative Solutions, Inc. | Method for denervation with reduced pain |
US10736524B2 (en) | 2013-10-25 | 2020-08-11 | Ablative Solutions, Inc. | Intravascular catheter with peri-vascular nerve activity sensors |
US11937933B2 (en) | 2013-10-25 | 2024-03-26 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US10022059B2 (en) | 2013-10-25 | 2018-07-17 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US11510729B2 (en) | 2013-10-25 | 2022-11-29 | Ablative Solutions, Inc. | Apparatus for effective ablation and nerve sensing associated with denervation |
US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
US10959941B2 (en) | 2014-05-29 | 2021-03-30 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US11992551B2 (en) | 2014-05-29 | 2024-05-28 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
US10543116B2 (en) | 2014-11-26 | 2020-01-28 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US11285029B2 (en) | 2014-11-26 | 2022-03-29 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US12226329B2 (en) | 2014-11-26 | 2025-02-18 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US11980379B2 (en) | 2014-11-26 | 2024-05-14 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US11253278B2 (en) | 2014-11-26 | 2022-02-22 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US10299948B2 (en) | 2014-11-26 | 2019-05-28 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US11712256B2 (en) | 2014-11-26 | 2023-08-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US11857210B2 (en) | 2014-11-26 | 2024-01-02 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11857444B2 (en) | 2014-11-26 | 2024-01-02 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
US20160243341A1 (en) * | 2015-02-25 | 2016-08-25 | Terumo Kabushiki Kaisha | Medical device, medical device assembly, balloon device, and treatment method for treating urethral stricture |
US10765838B2 (en) * | 2015-02-25 | 2020-09-08 | Terumo Kabushiki Kaisha | Medical device, medical device assembly, balloon device, and treatment method for treating urethral stricture |
US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
US10568752B2 (en) | 2016-05-25 | 2020-02-25 | W. L. Gore & Associates, Inc. | Controlled endoprosthesis balloon expansion |
US11779481B2 (en) | 2016-05-25 | 2023-10-10 | W. L. Gore & Associates, Inc. | Controlled endoprosthesis balloon expansion |
US12133657B2 (en) | 2016-09-06 | 2024-11-05 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US11147572B2 (en) | 2016-09-06 | 2021-10-19 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
US12226308B2 (en) | 2017-09-28 | 2025-02-18 | Glaukos Corporation | Method for controlling placement of intraocular implants |
US11116625B2 (en) | 2017-09-28 | 2021-09-14 | Glaukos Corporation | Apparatus and method for controlling placement of intraocular implants |
US12108982B2 (en) | 2018-07-18 | 2024-10-08 | Ablative Solutions, Inc. | Peri-vascular tissue access catheter with locking handle |
US10849685B2 (en) | 2018-07-18 | 2020-12-01 | Ablative Solutions, Inc. | Peri-vascular tissue access catheter with locking handle |
US10842498B2 (en) | 2018-09-13 | 2020-11-24 | Neuravi Limited | Systems and methods of restoring perfusion to a vessel |
US11406416B2 (en) | 2018-10-02 | 2022-08-09 | Neuravi Limited | Joint assembly for vasculature obstruction capture device |
US11963693B2 (en) | 2018-10-02 | 2024-04-23 | Neuravi Limited | Joint assembly for vasculature obstruction capture device |
US11065140B2 (en) * | 2019-01-08 | 2021-07-20 | Covidien Lp | Rotatable stent delivery apparatus to cover access site |
US11819432B2 (en) | 2019-01-08 | 2023-11-21 | Covidien Lp | Rotatable stent delivery apparatus to cover access site |
US11712231B2 (en) | 2019-10-29 | 2023-08-01 | Neuravi Limited | Proximal locking assembly design for dual stent mechanical thrombectomy device |
US12004731B2 (en) | 2019-10-29 | 2024-06-11 | Neuravi Limited | Proximal locking assembly design for dual stent mechanical thrombectomy device |
US11517340B2 (en) | 2019-12-03 | 2022-12-06 | Neuravi Limited | Stentriever devices for removing an occlusive clot from a vessel and methods thereof |
US12023058B2 (en) | 2019-12-03 | 2024-07-02 | Neuravi Limited | Stentriever devices for removing an occlusive clot from a vessel and methods thereof |
US11871946B2 (en) | 2020-04-17 | 2024-01-16 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11730501B2 (en) | 2020-04-17 | 2023-08-22 | Neuravi Limited | Floating clot retrieval device for removing clots from a blood vessel |
US12048446B2 (en) | 2020-04-17 | 2024-07-30 | Neuravi Limited | Clot retrieval device for removing heterogeneous clots from a blood vessel |
US11717308B2 (en) | 2020-04-17 | 2023-08-08 | Neuravi Limited | Clot retrieval device for removing heterogeneous clots from a blood vessel |
US10881541B1 (en) | 2020-05-01 | 2021-01-05 | Krishna Rocha-Singh | Systems and methods for treating venous compression/obstruction syndromes |
US11737771B2 (en) | 2020-06-18 | 2023-08-29 | Neuravi Limited | Dual channel thrombectomy device |
US12213691B2 (en) | 2020-06-18 | 2025-02-04 | Neuravi Limited | Dual channel thrombectomy device |
US11937836B2 (en) | 2020-06-22 | 2024-03-26 | Neuravi Limited | Clot retrieval system with expandable clot engaging framework |
US11439418B2 (en) | 2020-06-23 | 2022-09-13 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11395669B2 (en) | 2020-06-23 | 2022-07-26 | Neuravi Limited | Clot retrieval device with flexible collapsible frame |
US11864781B2 (en) | 2020-09-23 | 2024-01-09 | Neuravi Limited | Rotating frame thrombectomy device |
CN114652487A (en) * | 2020-12-23 | 2022-06-24 | 深圳市先健畅通医疗有限公司 | Support frame |
US11937837B2 (en) | 2020-12-29 | 2024-03-26 | Neuravi Limited | Fibrin rich / soft clot mechanical thrombectomy device |
US12029442B2 (en) | 2021-01-14 | 2024-07-09 | Neuravi Limited | Systems and methods for a dual elongated member clot retrieval apparatus |
US12064130B2 (en) | 2021-03-18 | 2024-08-20 | Neuravi Limited | Vascular obstruction retrieval device having sliding cages pinch mechanism |
US11974764B2 (en) | 2021-06-04 | 2024-05-07 | Neuravi Limited | Self-orienting rotating stentriever pinching cells |
Also Published As
Publication number | Publication date |
---|---|
US20010012961A1 (en) | 2001-08-09 |
WO2000048517A1 (en) | 2000-08-24 |
AU2992900A (en) | 2000-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6231597B1 (en) | Apparatus and methods for selectively stenting a portion of a vessel wall | |
US11406519B2 (en) | Protuberant aneurysm bridging device deployment method | |
US7063719B2 (en) | Stent devices with detachable distal or proximal wires | |
US9241815B2 (en) | Protuberant aneurysm bridging device and method of use | |
US6551305B2 (en) | Shape memory segmented detachable coil | |
CA2652176C (en) | Flexible vascular occluding device | |
JP4108273B2 (en) | Aneurysm occlusion and reinforcement method and device | |
EP2626038B1 (en) | Flexible vascular occluding device | |
US6494906B1 (en) | Stent fold clip | |
US8057495B2 (en) | Aneurysm occlusion device | |
US20050079196A1 (en) | Medical implant | |
WO2008157507A2 (en) | Blood flow diverters and aneurysm covering devices | |
JP2005522266A (en) | Fixation device for vascular occlusion device in aneurysm | |
WO2004034932A2 (en) | Stent assembly | |
EP1836998B1 (en) | Split sheath delivery system for self expanding stents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Fee payment |
Year of fee payment: 4 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Expired due to failure to pay maintenance fee |
Effective date: 20090515 |